Bengt Glimelius

Exploring Early Kinetic Profiles of CEA, ctDNA and cfDNA in Patients With RAS- /BRAF-Mutated Metastatic Colorectal Cancer

Hamfjord, Julian; Guren, Tormod Kyrre; Glimelius, Bengt; Sorbye, Halfdan et al.

Part of Clinical colorectal cancer, p. 153-158, 2025

• DOI for Exploring Early Kinetic Profiles of CEA, ctDNA and cfDNA in Patients With RAS- /BRAF-Mutated Metastatic Colorectal Cancer
• Download full text (pdf) of Exploring Early Kinetic Profiles of CEA, ctDNA and cfDNA in Patients With RAS- /BRAF-Mutated Metastatic Colorectal Cancer

Neo-adjuvant FOLFOX with and without panitumumab for patients with KRAS-wt locally advanced colon cancer: results following an extended biomarker panel on the FOxTROT trial embedded phase II population

Seligmann, J. F.; Morton, D.; Elliott, F.; Handley, K. et al.

Part of Annals of Oncology, p. 520-528, 2025

• DOI for Neo-adjuvant FOLFOX with and without panitumumab for patients with KRAS-wt locally advanced colon cancer: results following an extended biomarker panel on the FOxTROT trial embedded phase II population
• Download full text (pdf) of Neo-adjuvant FOLFOX with and without panitumumab for patients with KRAS-wt locally advanced colon cancer: results following an extended biomarker panel on the FOxTROT trial embedded phase II population

Perineal wound complications after total neoadjuvant therapy or chemoradiotherapy followed by abdominoperineal excision in patients with high-risk locally advanced rectal cancer in the RAPIDO trial

Zwart, Wouter H.; Dijkstra, Esmée A.; Hospers, Geke A. P.; Marijnen, Corrie A. M. et al.

Part of BJS Open, 2025

• DOI for Perineal wound complications after total neoadjuvant therapy or chemoradiotherapy followed by abdominoperineal excision in patients with high-risk locally advanced rectal cancer in the RAPIDO trial
• Download full text (pdf) of Perineal wound complications after total neoadjuvant therapy or chemoradiotherapy followed by abdominoperineal excision in patients with high-risk locally advanced rectal cancer in the RAPIDO trial

Treatment and survival of non-metastatic rectal cancer in patients with inflammatory bowel disease: nationwide cohort study

Lundqvist, Erik; Westberg, Karin; Dietrich, Caroline E.; Everhov, Åsa H. et al.

Part of BJS Open, 2025

• DOI for Treatment and survival of non-metastatic rectal cancer in patients with inflammatory bowel disease: nationwide cohort study
• Download full text (pdf) of Treatment and survival of non-metastatic rectal cancer in patients with inflammatory bowel disease: nationwide cohort study

Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial

Palmer, Daniel H.; Jackson, Richard; Springfeld, Christoph; Ghaneh, Paula et al.

Part of Journal of Clinical Oncology, p. 1240-1253, 2025

• DOI for Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial
• Download full text (pdf) of Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial

Exploring Early Kinetic Profiles of CEA, ctDNA and cfDNA in Patients With RAS- /BRAF-Mutated Metastatic Colorectal Cancer

Hamfjord, Julian; Guren, Tormod Kyrre; Glimelius, Bengt; Sorbye, Halfdan et al.

Part of Clinical colorectal cancer, p. 153-158, 2025

• DOI for Exploring Early Kinetic Profiles of CEA, ctDNA and cfDNA in Patients With RAS- /BRAF-Mutated Metastatic Colorectal Cancer
• Download full text (pdf) of Exploring Early Kinetic Profiles of CEA, ctDNA and cfDNA in Patients With RAS- /BRAF-Mutated Metastatic Colorectal Cancer

Neo-adjuvant FOLFOX with and without panitumumab for patients with KRAS-wt locally advanced colon cancer: results following an extended biomarker panel on the FOxTROT trial embedded phase II population

Seligmann, J. F.; Morton, D.; Elliott, F.; Handley, K. et al.

Part of Annals of Oncology, p. 520-528, 2025

• DOI for Neo-adjuvant FOLFOX with and without panitumumab for patients with KRAS-wt locally advanced colon cancer: results following an extended biomarker panel on the FOxTROT trial embedded phase II population
• Download full text (pdf) of Neo-adjuvant FOLFOX with and without panitumumab for patients with KRAS-wt locally advanced colon cancer: results following an extended biomarker panel on the FOxTROT trial embedded phase II population

Perineal wound complications after total neoadjuvant therapy or chemoradiotherapy followed by abdominoperineal excision in patients with high-risk locally advanced rectal cancer in the RAPIDO trial

Zwart, Wouter H.; Dijkstra, Esmée A.; Hospers, Geke A. P.; Marijnen, Corrie A. M. et al.

Part of BJS Open, 2025

• DOI for Perineal wound complications after total neoadjuvant therapy or chemoradiotherapy followed by abdominoperineal excision in patients with high-risk locally advanced rectal cancer in the RAPIDO trial
• Download full text (pdf) of Perineal wound complications after total neoadjuvant therapy or chemoradiotherapy followed by abdominoperineal excision in patients with high-risk locally advanced rectal cancer in the RAPIDO trial

Treatment and survival of non-metastatic rectal cancer in patients with inflammatory bowel disease: nationwide cohort study

Lundqvist, Erik; Westberg, Karin; Dietrich, Caroline E.; Everhov, Åsa H. et al.

Part of BJS Open, 2025

• DOI for Treatment and survival of non-metastatic rectal cancer in patients with inflammatory bowel disease: nationwide cohort study
• Download full text (pdf) of Treatment and survival of non-metastatic rectal cancer in patients with inflammatory bowel disease: nationwide cohort study

Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial

Palmer, Daniel H.; Jackson, Richard; Springfeld, Christoph; Ghaneh, Paula et al.

Part of Journal of Clinical Oncology, p. 1240-1253, 2025

• DOI for Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial
• Download full text (pdf) of Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial

Prognostic genome and transcriptome signatures in colorectal cancers

Nunes, Luís; Li, Fuqiang; Wu, Meizhen; Luo, Tian et al.

Part of Nature, p. 137-146, 2024

• DOI for Prognostic genome and transcriptome signatures in colorectal cancers
• Download full text (pdf) of Prognostic genome and transcriptome signatures in colorectal cancers

Time From Colorectal Cancer Surgery to Adjuvant Chemotherapy: Post Hoc Analysis of the SCOT Randomized Clinical Trial

Gögenur, Mikail; Weinberger Rosen, Andreas; Iveson, Timothy; Kerr, Rachel S. et al.

Part of JAMA Surgery, p. 865-871, 2024

• DOI for Time From Colorectal Cancer Surgery to Adjuvant Chemotherapy: Post Hoc Analysis of the SCOT Randomized Clinical Trial

ASO Visual Abstract: Risk Factors for Recurrence After Surgery for Rectal Cancer in a Modern, Nationwide Population-Based Cohort

Doroudian, Sepehr; Osterman, Erik; Glimelius, Bengt

Part of Annals of Surgical Oncology, p. 6414-6415, 2024

• DOI for ASO Visual Abstract: Risk Factors for Recurrence After Surgery for Rectal Cancer in a Modern, Nationwide Population-Based Cohort

Prognostic genome and transcriptome signatures in colorectal cancers

Nunes, Luís; Li, Fuqiang; Wu, Meizhen; Luo, Tian et al.

Part of Nature, p. 137-146, 2024

• DOI for Prognostic genome and transcriptome signatures in colorectal cancers

Comment on the RAPIDO Trial Point-Counterpoint Debate

Nilsson, Per J.; van Etten, Boudewijn; Hospers, Geke A. P.; Marijnen, Corrie A. M. et al.

Part of Diseases of the Colon & Rectum, 2024

• DOI for Comment on the RAPIDO Trial Point-Counterpoint Debate

Risk Factors for Recurrence After Surgery for Rectal Cancer in a Modern, Nationwide Population-Based Cohort

Doroudian, Sepehr; Osterman, Erik; Glimelius, Bengt

Part of Annals of Surgical Oncology, p. 5570-5584, 2024

• DOI for Risk Factors for Recurrence After Surgery for Rectal Cancer in a Modern, Nationwide Population-Based Cohort
• Download full text (pdf) of Risk Factors for Recurrence After Surgery for Rectal Cancer in a Modern, Nationwide Population-Based Cohort

Co-occurring mutations identify prognostic subgroups of microsatellite stable colorectal cancer

Nunes, Luís; Mørkved Stenersen, Jakob; Kryeziu, Kushtrim; Sjöblom, Tobias et al.

Part of Molecular Cancer, 2024

• DOI for Co-occurring mutations identify prognostic subgroups of microsatellite stable colorectal cancer
• Download full text (pdf) of Co-occurring mutations identify prognostic subgroups of microsatellite stable colorectal cancer

Oncological outcomes after a pathological complete response following total neoadjuvant therapy or chemoradiotherapy for high-risk locally advanced rectal cancer in the RAPIDO trial

Zwart, Wouter H.; Temmink, Sofieke J. D.; Hospers, Geke A. P.; Marijnen, Corrie A. M. et al.

Part of European Journal of Cancer, 2024

• DOI for Oncological outcomes after a pathological complete response following total neoadjuvant therapy or chemoradiotherapy for high-risk locally advanced rectal cancer in the RAPIDO trial
• Download full text (pdf) of Oncological outcomes after a pathological complete response following total neoadjuvant therapy or chemoradiotherapy for high-risk locally advanced rectal cancer in the RAPIDO trial

Implications of pretreatment extramural venous invasion in rectal cancer patients: A population-based study

Rutegard, Martin; Matthiessen, Peter; Glimelius, Bengt; Blomqvist, Lennart

Part of Colorectal Disease, p. 1388-1396, 2024

• DOI for Implications of pretreatment extramural venous invasion in rectal cancer patients: A population-based study
• Download full text (pdf) of Implications of pretreatment extramural venous invasion in rectal cancer patients: A population-based study

Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer

Hammarström, Klara; Nunes, Luís; Mathot, Lucy; Mezheyeuski, Artur et al.

Part of International Journal of Cancer, p. 40-53, 2024

• DOI for Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer
• Download full text (pdf) of Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer

Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US)

Glimelius, Bengt; Khan, Tanweera Shaheena; Adolfsson, Karin; Angenete, Eva et al.

Part of eClinicalMedicine, 2024

• DOI for Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US)
• Download full text (pdf) of Total neoadjuvant treatment using short-course radiotherapy and four CAPOX cycles in locally advanced rectal cancer with high-risk criteria for recurrence: a Swedish nationwide cohort study (LARCT-US)

Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study)

Kinos, Sampsa; Hagman, Helga; Halonen, Päivi; Soveri, Leena-Maija et al.

Part of Acta Oncologica, p. 248-258, 2024

• DOI for Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study)
• Download full text (pdf) of Detailed analysis of metastatic colorectal cancer patients who developed cardiotoxicity on another fluoropyrimidine and switched to S-1 treatment (subgroup analysis of the CardioSwitch-study)

The effect of BRAF^V600E mutation on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer: A post-hoc exploratory analysis of the randomized NORDIC9-study

Liposits, Gabor; Winther, Stine B.; Ryg, Jesper; Skuladottir, Halla et al.

Part of Journal of Geriatric Oncology, 2024

• DOI for The effect of BRAF^V600E mutation on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer: A post-hoc exploratory analysis of the randomized NORDIC9-study
• Download full text (pdf) of The effect of BRAF^V600E mutation on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer: A post-hoc exploratory analysis of the randomized NORDIC9-study

Impact of Primary Tumor Location on Demographics, Resectability, Outcomes, and Quality of Life in Finnish Metastatic Colorectal Cancer Patients (Subgroup Analysis of the RAXO Study)

Aho, Sonja; Österlund, Emerik; Ristimäki, Ari; Nieminen, Lasse et al.

Part of Cancers, 2024

• DOI for Impact of Primary Tumor Location on Demographics, Resectability, Outcomes, and Quality of Life in Finnish Metastatic Colorectal Cancer Patients (Subgroup Analysis of the RAXO Study)
• Download full text (pdf) of Impact of Primary Tumor Location on Demographics, Resectability, Outcomes, and Quality of Life in Finnish Metastatic Colorectal Cancer Patients (Subgroup Analysis of the RAXO Study)

Sensitive and Specific Analyses of Colorectal Cancer Recurrence through Multiplex superRCA Mutation Detection in Blood Plasma

Sandberg, Emma; Nunes, Luís; Edqvist, Per-Henrik; Mathot, Lucy et al.

Part of Cancers, 2024

• DOI for Sensitive and Specific Analyses of Colorectal Cancer Recurrence through Multiplex superRCA Mutation Detection in Blood Plasma
• Download full text (pdf) of Sensitive and Specific Analyses of Colorectal Cancer Recurrence through Multiplex superRCA Mutation Detection in Blood Plasma

Atypical (non‐V600E) BRAF mutations in metastatic colorectal cancer in population and real‐world cohorts

Österlund, Emerik; Ristimäki, Ari; Mäkinen, Markus J.; Kytölä, Soili et al.

Part of International Journal of Cancer, p. 488-503, 2024

• DOI for Atypical (non‐V600E) BRAF mutations in metastatic colorectal cancer in population and real‐world cohorts
• Download full text (pdf) of Atypical (non‐V600E) BRAF mutations in metastatic colorectal cancer in population and real‐world cohorts

Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy: The randomized NORDIC9-study

Liposits, Gabor; Ryg, Jesper; Skuladottir, Halla; Winther, Stine B. et al.

Part of Journal of Geriatric Oncology, 2023

• DOI for Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy: The randomized NORDIC9-study
• Download full text (pdf) of Prognostic value of baseline functional status measures and geriatric screening in vulnerable older patients with metastatic colorectal cancer receiving palliative chemotherapy: The randomized NORDIC9-study

Signet Ring Cell Colorectal and Appendiceal Cancer: A Small Signet Ring Cell Component Is Also Associated with Poor Outcome

Enblad, Malin; Pál Egerszegi, Péter; Birgisson, Helgi; Sjöblom, Tobias et al.

Part of Cancers, 2023

• DOI for Signet Ring Cell Colorectal and Appendiceal Cancer: A Small Signet Ring Cell Component Is Also Associated with Poor Outcome
• Download full text (pdf) of Signet Ring Cell Colorectal and Appendiceal Cancer: A Small Signet Ring Cell Component Is Also Associated with Poor Outcome

Resectability, Resections, Survival Outcomes, and Quality of Life in Older Adult Patients with Metastatic Colorectal Cancer (the RAXO-Study)

Lehtomaki, Kaisa; Soveri, Leena-Maija; Österlund, Emerik; Lamminmaki, Annamarja et al.

Part of Journal of Clinical Medicine, 2023

• DOI for Resectability, Resections, Survival Outcomes, and Quality of Life in Older Adult Patients with Metastatic Colorectal Cancer (the RAXO-Study)
• Download full text (pdf) of Resectability, Resections, Survival Outcomes, and Quality of Life in Older Adult Patients with Metastatic Colorectal Cancer (the RAXO-Study)

The value of post-operative chemotherapy after chemoradiotherapy in patients with high-risk locally advanced rectal cancerdresults from the RAPIDO trial

Dijkstra, E. A.; Zwart, W. H.; Nilsson, P. J.; Putter, H. et al.

Part of ESMO Open, 2023

• DOI for The value of post-operative chemotherapy after chemoradiotherapy in patients with high-risk locally advanced rectal cancerdresults from the RAPIDO trial

Low-dose aspirin use and colorectal cancer survival in 32,195 patients-A national cohort study

Shahrivar, Mehrnoosh; Weibull, Caroline E.; Ekström Smedby, Karin; Glimelius, Bengt et al.

Part of Cancer Medicine, p. 315-324, 2023

• DOI for Low-dose aspirin use and colorectal cancer survival in 32,195 patients-A national cohort study
• Download full text (pdf) of Low-dose aspirin use and colorectal cancer survival in 32,195 patients-A national cohort study

Sex differences in metastatic surgery following diagnosis of synchronous metastatic colorectal cancer

Ljunggren, Malin; Weibull, Caroline E.; Palmer, Gabriella; Österlund, Emerik et al.

Part of International Journal of Cancer, p. 363-373, 2023

• DOI for Sex differences in metastatic surgery following diagnosis of synchronous metastatic colorectal cancer
• Download full text (pdf) of Sex differences in metastatic surgery following diagnosis of synchronous metastatic colorectal cancer

Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery

Dijkstra, Esmee A.; Nilsson, Per J.; Hospers, Geke A. P.; Bahadoer, Renu R. et al.

Part of Annals of Surgery, 2023

• DOI for Locoregional Failure During and After Short-course Radiotherapy Followed by Chemotherapy and Surgery Compared With Long-course Chemoradiotherapy and Surgery

CRCBaSe: a Swedish register-based resource for colorectal adenocarcinoma research

Weibull, Caroline E.; Boman, Sol Erika; Glimelius, Bengt; Syk, Ingvar et al.

Part of Acta Oncologica, p. 342-349, 2023

• DOI for CRCBaSe: a Swedish register-based resource for colorectal adenocarcinoma research
• Download full text (pdf) of CRCBaSe: a Swedish register-based resource for colorectal adenocarcinoma research

Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial

Morton, Dion; Seymour, Matthew; Magill, Laura; Handley, Kelly et al.

Part of Journal of Clinical Oncology, p. 1541-+, 2023

• DOI for Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trial

Authors' reply-A sensitivity analysis of the RAPIDO clinical trial

Dijkstra, E. A.; Zwart, W. H.; Putter, H.; Marijnen, C. A. M. et al.

Part of Annals of Oncology, p. 446-447, 2023

• DOI for Authors' reply-A sensitivity analysis of the RAPIDO clinical trial

Risk and location of distant metastases in patients with locally advanced rectal cancer after total neoadjuvant treatment or chemoradiotherapy in the RAPIDO trial

Bahadoer, Renu R.; Hospers, Geke A. P.; Marijnen, Corrie A. M.; Peeters, Koen C. M. J. et al.

Part of European Journal of Cancer, p. 139-149, 2023

• DOI for Risk and location of distant metastases in patients with locally advanced rectal cancer after total neoadjuvant treatment or chemoradiotherapy in the RAPIDO trial
• Download full text (pdf) of Risk and location of distant metastases in patients with locally advanced rectal cancer after total neoadjuvant treatment or chemoradiotherapy in the RAPIDO trial

An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers

Mezheyeuski, Artur; Backman, Max; Mattsson, Johanna Sofia Margareta; Martin-Bernabe, Alfonso et al.

Part of EBioMedicine, 2023

• DOI for An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers
• Download full text (pdf) of An immune score reflecting pro- and anti-tumoural balance of tumour microenvironment has major prognostic impact and predicts immunotherapy response in solid cancers

Determinants of Pre-Surgical Treatment in Primary Rectal Cancer: A Population-Based Study

Imam, Israa; Hammarström, Klara; Glimelius, Bengt

Part of Cancers, 2023

• DOI for Determinants of Pre-Surgical Treatment in Primary Rectal Cancer: A Population-Based Study
• Download full text (pdf) of Determinants of Pre-Surgical Treatment in Primary Rectal Cancer: A Population-Based Study

Hospital factors and metastatic surgery in colorectal cancer patients, a population-based cohort study

Ljunggren, Malin; Weibull, Caroline E.; Rosander, Emma; Palmer, Gabriella et al.

Part of BMC Cancer, 2022

• DOI for Hospital factors and metastatic surgery in colorectal cancer patients, a population-based cohort study
• Download full text (pdf) of Hospital factors and metastatic surgery in colorectal cancer patients, a population-based cohort study

Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

Berndt, Sonja; Vijai, Joseph; Benavente, Yolanda; Camp, Nicola J. et al.

Part of Leukemia, p. 2835-2844, 2022

• DOI for Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes

Health-Related Quality of Life in Metastatic Colorectal Cancer Patients Treated with Curative Resection and/or Local Ablative Therapy or Systemic Therapy in the Finnish RAXO-Study

Lehtomaki, Kaisa; Stedt, Hanna P.; Österlund, Emerik; Muhonen, Timo et al.

Part of Cancers, 2022

• DOI for Health-Related Quality of Life in Metastatic Colorectal Cancer Patients Treated with Curative Resection and/or Local Ablative Therapy or Systemic Therapy in the Finnish RAXO-Study
• Download full text (pdf) of Health-Related Quality of Life in Metastatic Colorectal Cancer Patients Treated with Curative Resection and/or Local Ablative Therapy or Systemic Therapy in the Finnish RAXO-Study

Survival Trends of Right- and Left-Sided Colon Cancer across Four Decades: A Norwegian Population-Based Study

Hamfjord, Julian; Myklebust, Tor Age; Larsen, Inger Kristin; Kure, Elin H. et al.

Part of Cancer Epidemiology, Biomarkers and Prevention, p. 342-351, 2022

• DOI for Survival Trends of Right- and Left-Sided Colon Cancer across Four Decades: A Norwegian Population-Based Study
• Download full text (pdf) of Survival Trends of Right- and Left-Sided Colon Cancer across Four Decades: A Norwegian Population-Based Study

Calmangafodipir for Prevention of Oxaliplatin-Induced Peripheral Neuropathy: Two Placebo-Controlled, Randomized Phase 3 Studies (POLAR-A/POLAR-M)

Pfeiffer, Per; Lustberg, Maryam; Nasstrom, Jacques; Carlsson, Stefan et al.

Part of JNCI CANCER SPECTRUM, 2022

• DOI for Calmangafodipir for Prevention of Oxaliplatin-Induced Peripheral Neuropathy: Two Placebo-Controlled, Randomized Phase 3 Studies (POLAR-A/POLAR-M)

Mucinous rectal cancers: clinical features and prognosis in a population-based cohort

Enblad, Malin; Hammarström, Klara; Folkesson, Joakim; Imam, Israa et al.

Part of BJS Open, 2022

• DOI for Mucinous rectal cancers: clinical features and prognosis in a population-based cohort
• Download full text (pdf) of Mucinous rectal cancers: clinical features and prognosis in a population-based cohort

Temporal development in survival, and gender and regional differences in the Swedish population of patients with synchronous and metachronous metastatic colorectal cancer

Österlund, Emerik; Glimelius, Bengt

Part of Acta Oncologica, p. 1278-1288, 2022

• DOI for Temporal development in survival, and gender and regional differences in the Swedish population of patients with synchronous and metachronous metastatic colorectal cancer
• Download full text (pdf) of Temporal development in survival, and gender and regional differences in the Swedish population of patients with synchronous and metachronous metastatic colorectal cancer

KRAS-G12C Mutation in One Real-Life and Three Population-Based Nordic Cohorts of Metastatic Colorectal Cancer

Österlund, Emerik; Ristimaki, Ari; Kytola, Soili; Kuopio, Teijo et al.

Part of Frontiers in Oncology, 2022

• DOI for KRAS-G12C Mutation in One Real-Life and Three Population-Based Nordic Cohorts of Metastatic Colorectal Cancer
• Download full text (pdf) of KRAS-G12C Mutation in One Real-Life and Three Population-Based Nordic Cohorts of Metastatic Colorectal Cancer

Prognostic role of tumour-infiltrating lymphocytes and macrophages in relation to MSI, CDX2 and BRAF status: a population-based study of metastatic colorectal cancer patients

Aasebø, Kristine; Bruun, Jarle; Bergsland, Christian H; Nunes, Luís et al.

Part of British Journal of Cancer, p. 48-56, 2022

• DOI for Prognostic role of tumour-infiltrating lymphocytes and macrophages in relation to MSI, CDX2 and BRAF status: a population-based study of metastatic colorectal cancer patients

Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer - The RAPIDO trial

Dijkstra, Esmee A.; Hospers, Geke A. P.; Kranenbarg, Elma Meershoek-Klein; Fleer, Joke et al.

Part of Radiotherapy and Oncology, p. 69-76, 2022

• DOI for Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer - The RAPIDO trial
• Download full text (pdf) of Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer - The RAPIDO trial

Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy

Lagerlöf, Ingemar; Fohlin, Helena; Enblad, Gunilla; Glimelius, Bengt et al.

Part of Journal of Clinical Oncology, p. 1487-1496, 2022

• DOI for Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy
• Download full text (pdf) of Limited, But Not Eliminated, Excess Long-Term Morbidity in Stage I-IIA Hodgkin Lymphoma Treated With Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine and Limited-Field Radiotherapy

Associations between Response to Commonly Used Neo-Adjuvant Schedules in Rectal Cancer and Routinely Collected Clinical and Imaging Parameters

Karimi, Masoud; Osterlund, Pia; Hammarström, Klara; Imam, Israa et al.

Part of Cancers, 2022

• DOI for Associations between Response to Commonly Used Neo-Adjuvant Schedules in Rectal Cancer and Routinely Collected Clinical and Imaging Parameters
• Download full text (pdf) of Associations between Response to Commonly Used Neo-Adjuvant Schedules in Rectal Cancer and Routinely Collected Clinical and Imaging Parameters

Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study

Osterlund, P.; Kinos, S.; Pfeiffer, P.; Salminen, T. et al.

Part of ESMO Open, 2022

• DOI for Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study
• Download full text (pdf) of Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study

The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy-The Randomized NORDIC9-Study

Liposits, Gabor; Skuladottir, Halla; Ryg, Jesper; Winther, Stine Braendegaard et al.

Part of Journal of Clinical Medicine, 2022

• DOI for The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy-The Randomized NORDIC9-Study
• Download full text (pdf) of The Prognostic Value of Pre-Treatment Circulating Biomarkers of Systemic Inflammation (CRP, dNLR, YKL-40, and IL-6) in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy-The Randomized NORDIC9-Study

Current controversies in TNM for the radiological staging of rectal cancer and how to deal with them: results of a global online survey and multidisciplinary expert consensus

Lambregts, Doenja M. J.; Bogveradze, Nino; Blomqvist, Lennart K.; Fokas, Emmanouil et al.

Part of European Radiology, p. 4991-5003, 2022

• DOI for Current controversies in TNM for the radiological staging of rectal cancer and how to deal with them: results of a global online survey and multidisciplinary expert consensus
• Download full text (pdf) of Current controversies in TNM for the radiological staging of rectal cancer and how to deal with them: results of a global online survey and multidisciplinary expert consensus

Pretreatment MRI in Primary Rectal Cancer as a Predictor for Oncological Outcomes After Surgery for Local Recurrence

Elliot, Anders H.; Othman, Barwar N.; Suzuki, Chikako; Blomqvist, Lennart et al.

Part of Anticancer Research, p. 2459-2465, 2021

• DOI for Pretreatment MRI in Primary Rectal Cancer as a Predictor for Oncological Outcomes After Surgery for Local Recurrence

Quality of life assessments in clinical practice using either the EORTC-QLQ-C30 or the SEIOQL-DW: a randomized study

Kettis, Åsa; Fagerlind, Hanna; Frodin, Jan-Erik; Glimelius, Bengt et al.

Part of Journal of Patient-Reported Outcomes, 2021

• DOI for Quality of life assessments in clinical practice using either the EORTC-QLQ-C30 or the SEIOQL-DW: a randomized study
• Download full text (pdf) of Quality of life assessments in clinical practice using either the EORTC-QLQ-C30 or the SEIOQL-DW: a randomized study

Does exercise intensity matter for fatigue during (neo)adjuvant cancer treatment?: The PhysCan randomized clinical trial

Demmelmaier, Ingrid; Brooke, Hannah L.; Henriksson, Anna; Mazzoni, Anne-Sophie et al.

Part of Scandinavian Journal of Medicine and Science in Sports, p. 1144-1159, 2021

• DOI for Does exercise intensity matter for fatigue during (neo)adjuvant cancer treatment?: The PhysCan randomized clinical trial
• Download full text (pdf) of Does exercise intensity matter for fatigue during (neo)adjuvant cancer treatment?: The PhysCan randomized clinical trial

A Comprehensive Evaluation of Associations Between Routinely Collected Staging Information and The Response to (Chemo)Radiotherapy in Rectal Cancer

Hammarström, Klara; Imam, Israa; Mezheyeuski, Artur; Ekström, Joakim et al.

Part of Cancers, 2021

• DOI for A Comprehensive Evaluation of Associations Between Routinely Collected Staging Information and The Response to (Chemo)Radiotherapy in Rectal Cancer
• Download full text (pdf) of A Comprehensive Evaluation of Associations Between Routinely Collected Staging Information and The Response to (Chemo)Radiotherapy in Rectal Cancer

Clinicopathological factors associated with tumour-specific mutation detection in plasma of patients with RAS-mutated or BRAF-mutated metastatic colorectal cancer

Hamfjord, Julian; Guren, Tormod Kyrre; Glimelius, Bengt; Sorbye, Halfdan et al.

Part of International Journal of Cancer, p. 1385-1397, 2021

• DOI for Clinicopathological factors associated with tumour-specific mutation detection in plasma of patients with RAS-mutated or BRAF-mutated metastatic colorectal cancer
• Download full text (pdf) of Clinicopathological factors associated with tumour-specific mutation detection in plasma of patients with RAS-mutated or BRAF-mutated metastatic colorectal cancer

Interpreting the RAPIDO trial: factors to consider – Author's Reply

Bahadoer, Renu R.; Dijkstra, Esmée A.; van Etten, Boudewijn; Marijnen, Corrie A. M. et al.

Part of The Lancet Oncology, 2021

• DOI for Interpreting the RAPIDO trial: factors to consider – Author's Reply

Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

Bahadoer, Renu R.; Dijkstra, Esmee A.; van Etten, Boudewijn; Marijnen, Corrie A. M. et al.

Part of The Lancet Oncology, p. 29-42, 2021

• DOI for Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial

Completeness and accuracy of the registration of recurrences in the Swedish Colorectal Cancer Registry (SCRCR) and an update of recurrence risk in colon cancer

Osterman, Erik; Hammarström, Klara; Imam, Israa; Österlund, Emerik et al.

Part of Acta Oncologica, p. 842-849, 2021

• DOI for Completeness and accuracy of the registration of recurrences in the Swedish Colorectal Cancer Registry (SCRCR) and an update of recurrence risk in colon cancer

Accurate population-based model for individual prediction of colon cancer recurrence

Osterman, Erik; Ekström, Joakim; Sjöblom, Tobias; Kørner, Hartwig et al.

Part of Acta Oncologica, p. 1241-1249, 2021

• DOI for Accurate population-based model for individual prediction of colon cancer recurrence

Quality of Life in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy: The Randomized NORDIC9-Study

Liposits, Gabor; Eshoj, Henrik Rode; Möller, Sören; Braendegaard Winther, Stine et al.

Part of Cancers, 2021

• DOI for Quality of Life in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy: The Randomized NORDIC9-Study
• Download full text (pdf) of Quality of Life in Vulnerable Older Patients with Metastatic Colorectal Cancer Receiving Palliative Chemotherapy: The Randomized NORDIC9-Study

The Immune Landscape of Colorectal Cancer

Mezheyeuski, Artur; Micke, Patrick; Martin-Bernabe, Alfonso; Backman, Max et al.

Part of Cancers, 2021

• DOI for The Immune Landscape of Colorectal Cancer
• Download full text (pdf) of The Immune Landscape of Colorectal Cancer

hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA

Aughton, Karen; Elander, Nils O.; Evans, Anthony; Jackson, Richard et al.

Part of Cancers, 2021

• DOI for hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA
• Download full text (pdf) of hENT1 Predicts Benefit from Gemcitabine in Pancreatic Cancer but Only with Low CDA mRNA

Neoadjuvant rectal (NAR) score: Value evaluating the efficacy of neoadjuvant therapy and prognostic significance after surgery?

Imam, Israa; Hammarström, Klara; Sjöblom, Tobias; Glimelius, Bengt

Part of Radiotherapy and Oncology, p. 70-77, 2021

• DOI for Neoadjuvant rectal (NAR) score: Value evaluating the efficacy of neoadjuvant therapy and prognostic significance after surgery?
• Download full text (pdf) of Neoadjuvant rectal (NAR) score: Value evaluating the efficacy of neoadjuvant therapy and prognostic significance after surgery?

Radiotherapy regimens for rectal cancer: long-term outcomes and health-related quality of life in the Stockholm III trial

Erlandsson, Johan; Fuentes, Stina; Radu, Calin; Frödin, Jan-Erik et al.

Part of BJS Open, 2021

• DOI for Radiotherapy regimens for rectal cancer: long-term outcomes and health-related quality of life in the Stockholm III trial
• Download full text (pdf) of Radiotherapy regimens for rectal cancer: long-term outcomes and health-related quality of life in the Stockholm III trial

TOSCA-a delicious Swedish almond cake, an Italian opera and an Italian trial with important new data

Glimelius, Bengt

Part of Annals of Oncology, p. 6-8, 2021

• DOI for TOSCA-a delicious Swedish almond cake, an Italian opera and an Italian trial with important new data

Investigation of Relation of Radiation Therapy Quality With Toxicity and Survival in LAP07 Phase 3 Trial for Locally Advanced Pancreatic Carcinoma

Giraud, Paul; Racadot, Severine; Vernerey, Dewi; Goldstein, David et al.

Part of International Journal of Radiation Oncology, Biology, Physics, p. 993-1002, 2021

• DOI for Investigation of Relation of Radiation Therapy Quality With Toxicity and Survival in LAP07 Phase 3 Trial for Locally Advanced Pancreatic Carcinoma

Predictive Value of Neutrophils Count for Local Tumor Control After Chemoradiotherapy in Patients With Locally Advanced Pancreatic Carcinoma

Schernberg, Antoine; Vernerey, Dewi; Goldstein, David; van Laethem, Jean-Luc et al.

Part of International Journal of Radiation Oncology, Biology, Physics, p. 1022-1031, 2021

• DOI for Predictive Value of Neutrophils Count for Local Tumor Control After Chemoradiotherapy in Patients With Locally Advanced Pancreatic Carcinoma

Three Versus Six Months of Adjuvant Doublet Chemotherapy for Patients With Colorectal Cancer: A Multi-Country Cost-Effectiveness and Budget Impact Analysis

Hanna, Catherine R.; Robles-Zurita, Jose A.; Briggs, Andrew; Harkin, Andrea et al.

Part of Clinical colorectal cancer, p. 236-244, 2021

• DOI for Three Versus Six Months of Adjuvant Doublet Chemotherapy for Patients With Colorectal Cancer: A Multi-Country Cost-Effectiveness and Budget Impact Analysis
• Download full text (pdf) of Three Versus Six Months of Adjuvant Doublet Chemotherapy for Patients With Colorectal Cancer: A Multi-Country Cost-Effectiveness and Budget Impact Analysis

The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types

Micke, Patrick; Strell, Carina; Mattsson, Johanna Sofia Margareta; Martin-Bernabe, Alfonso et al.

Part of EBioMedicine, 2021

• DOI for The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types
• Download full text (pdf) of The prognostic impact of the tumour stroma fraction: A machine learning-based analysis in 16 human solid tumour types

Molecular characterization of a large unselected cohort of metastatic colorectal cancers in relation to primary tumor location, rare metastatic sites and prognosis

Nunes, Luís; Aasebø, Kristine; Mathot, Lucy; Ljungström, Viktor et al.

Part of Acta Oncologica, p. 417-426, 2020

• DOI for Molecular characterization of a large unselected cohort of metastatic colorectal cancers in relation to primary tumor location, rare metastatic sites and prognosis
• Download full text (pdf) of Molecular characterization of a large unselected cohort of metastatic colorectal cancers in relation to primary tumor location, rare metastatic sites and prognosis

CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup

Aasebo, Kristine; Dragomir, Anca; Sundström, Magnus; Mezheyeuski, Artur et al.

Part of Frontiers in Oncology, 2020

• DOI for CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup
• Download full text (pdf) of CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup

Genetically Determined Height and Risk of Non-hodgkin Lymphoma

Moore, Amy; Kane, Eleanor; Wang, Zhaoming; Panagiotou, Orestis A. et al.

Part of Frontiers in Oncology, 2020

• DOI for Genetically Determined Height and Risk of Non-hodgkin Lymphoma
• Download full text (pdf) of Genetically Determined Height and Risk of Non-hodgkin Lymphoma

No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy

Lagerlöf, Ingemar; Holte, Harald; Glimelius, Ingrid; Björkholm, Magnus et al.

Part of British Journal of Haematology, p. 685-691, 2020

• DOI for No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy

Metastatic colorectal carcinomas with high SATB2 expression are associated with better prognosis and response to chemotherapy: a population-based Scandinavian study

Mezheyeuski, Artur; Pontén, Fredrik; Edqvist, Per-Henrik D; Sundström, Magnus et al.

Part of Acta Oncologica, p. 284-290, 2020

• DOI for Metastatic colorectal carcinomas with high SATB2 expression are associated with better prognosis and response to chemotherapy: a population-based Scandinavian study
• Download full text (pdf) of Metastatic colorectal carcinomas with high SATB2 expression are associated with better prognosis and response to chemotherapy: a population-based Scandinavian study

Beyond the NCCN Risk Factors in Colon Cancer: An Evaluation in a Swedish Population-Based Cohort

Osterman, Erik; Mezheyeuski, Artur; Sjöblom, Tobias; Glimelius, Bengt

Part of Annals of Surgical Oncology, p. 1036-1045, 2020

• DOI for Beyond the NCCN Risk Factors in Colon Cancer: An Evaluation in a Swedish Population-Based Cohort
• Download full text (pdf) of Beyond the NCCN Risk Factors in Colon Cancer: An Evaluation in a Swedish Population-Based Cohort

Evaluation of the stage classification of anal cancer by the TNM 8th version versus the TNM 7th version

Dahl, Olav; Myklebust, Mette Pernille; Dale, Jon Espen; Leon, Otilia et al.

Part of Acta Oncologica, p. 1016-1023, 2020

• DOI for Evaluation of the stage classification of anal cancer by the TNM 8th version versus the TNM 7th version

Evaluation of the antibody response to the EBV proteome in EBV-associated classical Hodgkin lymphoma

Liu, Zhiwei; Jarrett, Ruth F.; Hjalgrim, Henrik; Proietti, Carla et al.

Part of International Journal of Cancer, p. 608-618, 2020

• DOI for Evaluation of the antibody response to the EBV proteome in EBV-associated classical Hodgkin lymphoma

ASO Author Reflections: Emerging Risk Factors in Colon Cancer — End of the Line for Clinomics?

Osterman, Erik; Glimelius, Bengt

Part of Annals of Surgical Oncology, p. 1046-1047, 2020

• DOI for ASO Author Reflections: Emerging Risk Factors in Colon Cancer — End of the Line for Clinomics?
• Download full text (pdf) of ASO Author Reflections: Emerging Risk Factors in Colon Cancer — End of the Line for Clinomics?

Prognostic Interactions between FAP plus Fibroblasts and CD8a+T Cells in Colon Cancer

Herrera, Mercedes; Mezheyeuski, Artur; Villabona, Lisa; Corvigno, Sara et al.

Part of Cancers, 2020

• DOI for Prognostic Interactions between FAP plus Fibroblasts and CD8a+T Cells in Colon Cancer
• Download full text (pdf) of Prognostic Interactions between FAP plus Fibroblasts and CD8a+T Cells in Colon Cancer

Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - Results of the international randomized RAPIDO-trial

van der Valk, Maxime J. M.; Marijnen, Corrie A. M.; van Etten, Boudewijn; Dijkstra, Esmee A. et al.

Part of Radiotherapy and Oncology, p. 75-83, 2020

• DOI for Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer - Results of the international randomized RAPIDO-trial

International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic

Marijnen, C. A. M.; Peters, F. P.; Roedel, C.; Bujko, K. et al.

Part of Radiotherapy and Oncology, p. 213-215, 2020

• DOI for International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic

Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients

Sclafani, Francesco; Wilson, Sanna Hulkki; Cunningham, David; De Castro, David Gonzalez et al.

Part of International Journal of Cancer, p. 94-102, 2020

• DOI for Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients

Consequences of a high incidence of microsatellite instability and BRAF-mutated tumors: A population-based cohort of metastatic colorectal cancer patients

Aasebö, Kristine Ö.; Dragomir, Anca; Sundström, Magnus; Mezheyeuski, Artur et al.

Part of Cancer Medicine, p. 3623-3635, 2019

• DOI for Consequences of a high incidence of microsatellite instability and BRAF-mutated tumors: A population-based cohort of metastatic colorectal cancer patients
• Download full text (pdf) of Consequences of a high incidence of microsatellite instability and BRAF-mutated tumors: A population-based cohort of metastatic colorectal cancer patients

Determining the use of preoperative (chemo)radiotherapy in primary rectal cancer according to national and international guidelines

Hammarström, Klara; Imam, Israa; Korsavidou Hult, Nafsika; Ekström, Joakim et al.

Part of Radiotherapy and Oncology, p. 106-112, 2019

• DOI for Determining the use of preoperative (chemo)radiotherapy in primary rectal cancer according to national and international guidelines

Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes

Din, Lennox; Sheikh, Mohammad; Kosaraju, Nikitha; Smedby, Karin Ekstrom et al.

Part of Genetic Epidemiology, p. 844-863, 2019

• DOI for Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes

Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy

Hamfjord, J.; Guren, T. K.; Dajani, O.; Johansen, J. S. et al.

Part of Annals of Oncology, p. 1088-1095, 2019

• DOI for Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy
• Download full text (pdf) of Total circulating cell-free DNA as a prognostic biomarker in metastatic colorectal cancer before first-line oxaliplatin-based chemotherapy

3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT

Ivesono, Timothy; Boydo, Kathleen A.; Kerro, Rachel S.; Robles-Zuritao, Jose et al.

Part of Health Technology Assessment, p. 1-88, 2019

• DOI for 3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT
• Download full text (pdf) of 3-month versus 6-month adjuvant chemotherapy for patients with high-risk stage II and III colorectal cancer: 3-year follow-up of the SCOT non-inferiority RCT

Definition of the Rectum An International, Expert-based Delphi Consensus

D'Souza, Nigel; Babberich, Michael P. M. de Neree Tot; d'Hoore, Andre; Tiret, Emmanuel et al.

Part of Annals of Surgery, p. 955-959, 2019

• DOI for Definition of the Rectum An International, Expert-based Delphi Consensus

Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial

Jones, Robert P.; Psarelli, Eftychia-Eirini; Jackson, Richard; Ghaneh, Paula et al.

Part of JAMA Surgery, p. 1038-1048, 2019

• DOI for Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial

Stroma-normalised vessel density predicts benefit from adjuvant fluorouracil-based chemotherapy in patients with stage II/III colon cancer

Mezheyeuski, Artur; Hrynchyk, Ina; Herrera, Mercedes; Karlberg, Mia et al.

Part of British Journal of Cancer, p. 303-311, 2019

• DOI for Stroma-normalised vessel density predicts benefit from adjuvant fluorouracil-based chemotherapy in patients with stage II/III colon cancer

Predicting mortality and adverse events in patients with advanced pancreatic cancer treated with palliative gemcitabine-based chemotherapy in a multicentre phase III randomized clinical trial: the APC-SAKK risk scores

Gargiulo, Piera; Dietrich, Daniel; Herrmann, Richard; Bodoky, Gyorgy et al.

Part of THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2019

• DOI for Predicting mortality and adverse events in patients with advanced pancreatic cancer treated with palliative gemcitabine-based chemotherapy in a multicentre phase III randomized clinical trial: the APC-SAKK risk scores
• Download full text (pdf) of Predicting mortality and adverse events in patients with advanced pancreatic cancer treated with palliative gemcitabine-based chemotherapy in a multicentre phase III randomized clinical trial: the APC-SAKK risk scores

An audit of performance, interpretation, and influence of pretherapeutic MRI in rectal cancer: a Swedish population-based cohort study

Elliot, Anders H.; Blomqvist, Lennart; Sigurdsson, Arni; Martling, Anna et al.

Part of Acta Radiologica, p. 955-961, 2019

• DOI for An audit of performance, interpretation, and influence of pretherapeutic MRI in rectal cancer: a Swedish population-based cohort study

Postoperative complications in relation to overall treatment time in patients with rectal cancer receiving neoadjuvant radiotherapy

Erlandsson, J.; Pettersson, D.; Glimelius, Bengt; Holm, T. et al.

Part of British Journal of Surgery, p. 1248-1256, 2019

• DOI for Postoperative complications in relation to overall treatment time in patients with rectal cancer receiving neoadjuvant radiotherapy

Tumour regression after radiotherapy for rectal cancer - Results from the randomised Stockholm III trial

Erlandsson, Johan; Lorinc, Ester; Ahlberga, Madelene; Pettersson, David et al.

Part of Radiotherapy and Oncology, p. 178-186, 2019

• DOI for Tumour regression after radiotherapy for rectal cancer - Results from the randomised Stockholm III trial

The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma

Ghaneh, Paula; Kleeff, Jorg; Halloran, Christopher M.; Raraty, Michael et al.

Part of Annals of Surgery, p. 520-529, 2019

• DOI for The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma

Lessons learned from the maturation of a cancer drug: oxaliplatin in colorectal cancer

Glimelius, Bengt; Nygren, Peter

Part of Acta Oncologica, p. 395-397, 2019

• DOI for Lessons learned from the maturation of a cancer drug: oxaliplatin in colorectal cancer

Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full- dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial

Whither, Stine Braendegaard; Liposits, Gabor; Skuladottir, Haifa; Hofsli, Eva et al.

Part of The Lancet Gastroenterology & Hepatology, p. 376-388, 2019

• DOI for Reduced-dose combination chemotherapy (S-1 plus oxaliplatin) versus full- dose monotherapy (S-1) in older vulnerable patients with metastatic colorectal cancer (NORDIC9): a randomised, open-label phase 2 trial

Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study

Majano, Sara Benitez; Di Girolamo, Chiara; Rachet, Bernard; Maringe, Camille et al.

Part of The Lancet Oncology, p. 74-87, 2019

• DOI for Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study
• Download full text (pdf) of Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study

U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden.

Glimelius, Bengt; Melin, Beatrice; Enblad, Gunilla; Alafuzoff, Irina et al.

Part of Acta Oncologica, p. 187-194, 2018

• DOI for U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden.
• Download full text (pdf) of U-CAN: a prospective longitudinal collection of biomaterials and clinical information from adult cancer patients in Sweden.

Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx^®): a placebo-controlled randomised phase II study (PLIANT)

Glimelius, Bengt; Manojlovic, Nebojsa; Pfeiffer, Per; Mosidze, Baadur et al.

Part of Acta Oncologica, p. 393-402, 2018

• DOI for Persistent prevention of oxaliplatin-induced peripheral neuropathy using calmangafodipir (PledOx^®): a placebo-controlled randomised phase II study (PLIANT)

Session 4: What should we do for poor responders after chemoradiotherapy: bad biology or should the fight go on?

Bhoday, J.; Glimelius, Bengt; Tait, D.; Glynne-Jones, R. et al.

Part of Colorectal Disease, p. 97-99, 2018

• DOI for Session 4: What should we do for poor responders after chemoradiotherapy: bad biology or should the fight go on?

Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia

McMaster, Mary L.; Berndt, Sonja; Zhang, Jianqing; Slager, Susan L. et al.

Part of Nature Communications, 2018

• DOI for Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia
• Download full text (pdf) of Two high-risk susceptibility loci at 6p25.3 and 14q32.13 for Waldenström macroglobulinemia

Stage distribution utilizing magnetic resonance imaging in an unselected population of primary rectal cancers

Hammarström, Klara; Mezheyeuski, Artur; Korsavidou Hult, Nafsika; Sjöblom, Tobias et al.

Part of European Journal of Surgical Oncology, p. 1858-1864, 2018

• DOI for Stage distribution utilizing magnetic resonance imaging in an unselected population of primary rectal cancers

Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis

Kleinstern, Geffen; Camp, Nicola J.; Goldin, Lynn R.; Vachon, Celine M. et al.

Part of Blood, p. 2541-2551, 2018

• DOI for Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis

KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer

Sclafani, Francesco; Chau, Ian; Cunningham, David; Hahne, Jens C. et al.

Part of Scientific Reports, 2018

• DOI for KRAS and BRAF mutations in circulating tumour DNA from locally advanced rectal cancer

Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer

Elander, N. O.; Aughton, K.; Ghaneh, P.; Neoptolemos, J. P. et al.

Part of British Journal of Cancer, p. 947-954, 2018

• DOI for Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer
• Download full text (pdf) of Expression of dihydropyrimidine dehydrogenase (DPD) and hENT1 predicts survival in pancreatic cancer

Recurrence Risk After Up-to-Date Colon Cancer Staging, Surgery, and Pathology: Analysis of the Entire Swedish Population.

Osterman, Erik; Glimelius, Bengt

Part of Diseases of the Colon & Rectum, p. 1016-1025, 2018

• DOI for Recurrence Risk After Up-to-Date Colon Cancer Staging, Surgery, and Pathology: Analysis of the Entire Swedish Population.
• Download full text (pdf) of Recurrence Risk After Up-to-Date Colon Cancer Staging, Surgery, and Pathology: Analysis of the Entire Swedish Population.

Treatment-related survival associations of claudin-2 expression in fibroblasts of colorectal cancer

Mezheyeuski, Artur; Strell, Carina; Hrynchyk, Ina; Guren, Tormod Kyrre et al.

Part of Virchows Archiv, p. 395-405, 2018

• DOI for Treatment-related survival associations of claudin-2 expression in fibroblasts of colorectal cancer
• Download full text (pdf) of Treatment-related survival associations of claudin-2 expression in fibroblasts of colorectal cancer

Forty-five years in oncology, 25 years with Acta Oncologica

Glimelius, Bengt

Part of Acta Oncologica, p. 1593-1598, 2018

• DOI for Forty-five years in oncology, 25 years with Acta Oncologica

Do we make progress in elderly patients with metastatic colorectal cancer?

Glimelius, Bengt; Pfeiffer, Per

Part of Acta Oncologica, p. 1422-1426, 2018

• DOI for Do we make progress in elderly patients with metastatic colorectal cancer?

SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer

Robles-Zurita, Jose; Boyd, Kathleen A.; Briggs, Andrew H.; Iveson, Timothy et al.

Part of British Journal of Cancer, p. 1332-1338, 2018

• DOI for SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer

Total circulating cell-free DNA (cfDNA) as a prognostic biomarker in metastatic colorectal cancer prior to first-line oxaliplatin-based chemotherapy

Hamfjord, J.; Guren, T.; Dajani, O.; Glimelius, Bengt et al.

Part of Annals of Oncology, 2018

• DOI for Total circulating cell-free DNA (cfDNA) as a prognostic biomarker in metastatic colorectal cancer prior to first-line oxaliplatin-based chemotherapy

The PLIANT trial gives trustworthy data

Glimelius, Bengt; Kowalski, Jan; Nasstrom, Jacques

Part of Acta Oncologica, p. 864-866, 2018

• DOI for The PLIANT trial gives trustworthy data

HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes

Wang, Sophia S.; Carrington, Mary; Berndt, Sonja I.; Slager, Susan L. et al.

Part of Cancer Research, p. 4086-4096, 2018

• DOI for HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes

Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group

Goey, Kaitlyn K. H.; Sorbye, Halfdan; Glimelius, Bengt; Adams, Richard A. et al.

Part of European Journal of Cancer, p. 35-45, 2018

• DOI for Consensus statement on essential patient characteristics in systemic treatment trials for metastatic colorectal cancer: Supported by the ARCAD Group

Quality of life and cost effectiveness in a randomized trial of patients with colorectal cancer and peritoneal metastases

Cashin, Peter; Mahteme, Haile; Syk, I.; Frodin, J. E. et al.

Part of European Journal of Surgical Oncology, p. 983-990, 2018

• DOI for Quality of life and cost effectiveness in a randomized trial of patients with colorectal cancer and peritoneal metastases

Preoperative radiotherapy or chemoradiotherapy in rectal cancer - Is survival improved?: An update of the "Nordic" LARC study in non-resectable cancers

Braendengen, Morten; Glimelius, Bengt

Part of Radiotherapy and Oncology, p. 392-395, 2018

• DOI for Preoperative radiotherapy or chemoradiotherapy in rectal cancer - Is survival improved?: An update of the "Nordic" LARC study in non-resectable cancers

Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome

Thomsen, Maria; Skovlund, Eva; Sorbye, Halfdan; Bolstad, Nils et al.

Part of British Journal of Cancer, p. 1609-1616, 2018

• DOI for Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome
• Download full text (pdf) of Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer: a BRAF-mutant subset with high CA 19-9 level and poor outcome

What treatments should be skipped or intensified in localized rectal cancer?

Glimelius, Bengt

Part of Future Oncology, p. 313-318, 2018

• DOI for What treatments should be skipped or intensified in localized rectal cancer?

3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial

Iveson, Timothy J.; Kerr, Rachel S.; Saunders, Mark P.; Cassidy, Jim et al.

Part of The Lancet Oncology, p. 562-578, 2018

• DOI for 3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial
• Download full text (pdf) of 3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial

Neoadjuvant Therapy in Rectal Cancer Patients With Clinical Stage II to III Across European Countries: Variations and Outcomes

Babaei, Masoud; Jansen, Lina; Balavarca, Yesilda; Sjovall, Annika et al.

Part of Clinical colorectal cancer, 2018

• DOI for Neoadjuvant Therapy in Rectal Cancer Patients With Clinical Stage II to III Across European Countries: Variations and Outcomes

Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy

Elander, N. O.; Aughton, K.; Ghaneh, P.; Neoptolemos, J. P. et al.

Part of British Journal of Cancer, p. 1084-1088, 2018

• DOI for Intratumoural expression of deoxycytidylate deaminase or ribonuceotide reductase subunit M1 expression are not related to survival in patients with resected pancreatic cancer given adjuvant chemotherapy

Short- and long-term risks of cardiovascular disease following radiotherapy in rectal cancer in four randomized controlled trials and a population-based register

Chen, Lingjing; Eloranta, Sandra; Martling, Anna; Glimelius, Ingrid et al.

Part of Radiotherapy and Oncology, p. 424-430, 2018

• DOI for Short- and long-term risks of cardiovascular disease following radiotherapy in rectal cancer in four randomized controlled trials and a population-based register

More than 1000 new manuscripts in 2017

Glimelius, Bengt

Part of Acta Oncologica, p. 174-175, 2018

• DOI for More than 1000 new manuscripts in 2017

Administration of adjuvant chemotherapy for stage II-III colon cancer patients: An European population-based study

Babaei, Masoud; Balavarca, Yesilda; Jansen, Lina; Lemmens, Valery et al.

Part of International Journal of Cancer, p. 1480-1489, 2018

• DOI for Administration of adjuvant chemotherapy for stage II-III colon cancer patients: An European population-based study

Different functions of AKT1 and AKT2 in molecular pathways, cell migration and metabolism in colon cancer cells

Häggblad Sahlberg, Sara; Mortensen, Anja C.; Haglöf, Jakob; Engskog, Mikael K. R. et al.

Part of International Journal of Oncology, p. 5-14, 2017

• DOI for Different functions of AKT1 and AKT2 in molecular pathways, cell migration and metabolism in colon cancer cells
• Download full text (pdf) of Different functions of AKT1 and AKT2 in molecular pathways, cell migration and metabolism in colon cancer cells

How Relevant Is Treatment-Related Infertility for Individual Treatment Selection in Hodgkin Lymphoma?: Reply to C.F. Hess et al

Carde, Patrice P.; Grynberg, Michael; Poirot, Catherine; Glimelius, Bengt et al.

Part of Journal of Clinical Oncology, p. 374-374, 2017

• DOI for How Relevant Is Treatment-Related Infertility for Individual Treatment Selection in Hodgkin Lymphoma?: Reply to C.F. Hess et al

Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients with metastatic colorectal cancer: NORDIC 9

Winther, Stine Braendegaard; Österlund, Pia; Berglund, Åke; Glimelius, Bengt et al.

Part of BMC Cancer, 2017

• DOI for Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients with metastatic colorectal cancer: NORDIC 9
• Download full text (pdf) of Randomized study comparing full dose monotherapy (S-1 followed by irinotecan) and reduced dose combination therapy (S-1/oxaliplatin followed by S-1/irinotecan) as initial therapy for older patients with metastatic colorectal cancer: NORDIC 9

Prognostic factors in patients with loco-regionally advanced gastric cancer

Hultman, Bo; Gunnarsson, Ulf; Nygren, Peter; Sundbom, Magnus et al.

Part of World Journal of Surgical Oncology, 2017

• DOI for Prognostic factors in patients with loco-regionally advanced gastric cancer
• Download full text (pdf) of Prognostic factors in patients with loco-regionally advanced gastric cancer

Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia

Law, Phillip J.; Berndt, Sonja I.; Speedy, Helen E.; Camp, Nicola J. et al.

Part of Nature Communications, 2017

• DOI for Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia
• Download full text (pdf) of Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia

Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma

Bernatsky, Sasha; Garcia, Hector A. Velasquez; Spinelli, John J.; Gaffney, Patrick et al.

Part of Lupus Science and Medicine, 2017

• DOI for Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma

High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer

Siesing, Christina; Sorbye, Halfdan; Dragomir, Anca; Pfeiffer, Per et al.

Part of PLOS ONE, 2017

• DOI for High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer
• Download full text (pdf) of High RBM3 expression is associated with an improved survival and oxaliplatin response in patients with metastatic colorectal cancer

Associations of defect mismatch repair genes with prognosis and heredity in sporadic colorectal cancer

Ghanipour, Lana; Jirström, Karin; Sundström, Magnus; Glimelius, Bengt et al.

Part of European Journal of Surgical Oncology, p. 311-321, 2017

• DOI for Associations of defect mismatch repair genes with prognosis and heredity in sporadic colorectal cancer

Somatic Ephrin Receptor Mutations Are Associated with Metastasis in Primary Colorectal Cancer

Mathot, Lucy; Kundu, Snehangshu; Ljungström, Viktor; Svedlund, Jessica et al.

Part of Cancer Research, p. 1730-1740, 2017

• DOI for Somatic Ephrin Receptor Mutations Are Associated with Metastasis in Primary Colorectal Cancer

A pathology atlas of the human cancer transcriptome

Uhlen, Mathias; Zhang, Cheng; Lee, Sunjae; Sjöstedt, Evelina et al.

Part of Science, 2017

• DOI for A pathology atlas of the human cancer transcriptome

Two countries - two treatment strategies for rectal cancer

Guren, M.; Myklebust, T. A.; Lundqvist, K.; Wibe, A. et al.

Part of European Journal of Cancer, 2017

• DOI for Two countries - two treatment strategies for rectal cancer

Updated results of the SCOT study: An international phase III randomised (1:1) non-inferiority trial comparing 3 versus 6 months of oxaliplatin based adjuvant chemotherapy for colorectal cancer

Iveson, T.; Kerr, R.; Saunders, M.; Hollander, N. et al.

Part of Annals of Oncology, 2017

Comparison between magnetic resonance imaging (MRI) and pathology in the assessment of tumour regression grade (TRG) in rectal cancer (RC)

Sclafani, F.; Brown, G.; Cunningham, D.; Wotherspoon, A. et al.

Part of Annals of Oncology, 2017

COnsensus statement on Mandatory Measurements in PAncreatic Cancer Trials for systemic treatment of unresectable disease (COMMPACT)

van Rijssen, L. B.; ter Veer, E.; Besselink, M. G.; Mali, R. M. A. et al.

Part of Annals of Oncology, 2017

Neutrophils Predicting Tumor Local Control After Chemoradiation Therapy in Locally Advanced Pancreatic Carcinoma in the LAP 07 Trial

Schernberg, A.; Vernerey, D.; Goldstein, D.; Van Laethem, J. L. et al.

Part of International Journal of Radiation Oncology, Biology, Physics, 2017

What conclusions can be drawn from the Stockholm III rectal cancer trial in the era of watch and wait?

Glimelius, Bengt; Martling, A.

Part of Acta Oncologica, p. 1139-1142, 2017

• DOI for What conclusions can be drawn from the Stockholm III rectal cancer trial in the era of watch and wait?

Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer

Sclafani, Francesco; Brown, Gina; Cunningham, David; Wotherspoon, Andrew et al.

Part of British Journal of Cancer, p. 1478-1485, 2017

• DOI for Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancer

Health-related quality of life in patients with metastatic colorectal cancer, association with systemic inflammatory response and RAS and BRAF mutation status

Thomsen, Maria; Guren, Marianne Gronlie; Skovlund, Eva; Glimelius, Bengt et al.

Part of European Journal of Cancer, p. 26-35, 2017

• DOI for Health-related quality of life in patients with metastatic colorectal cancer, association with systemic inflammatory response and RAS and BRAF mutation status

Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

Neoptolemos, John P.; Palmer, Daniel H.; Ghaneh, Paula; Psarelli, Eftychia E. et al.

Part of The Lancet, p. 1011-1024, 2017

• DOI for Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
• Download full text (pdf) of Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial

Risk of second primary cancer in patients treated with radiotherapy for rectal cancer

Martling, A.; Smedby, K. E.; Birgisson, Helgi; Olsson, H. et al.

Part of British Journal of Surgery, p. 278-287, 2017

• DOI for Risk of second primary cancer in patients treated with radiotherapy for rectal cancer

Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial

Erlandsson, Johan; Holm, Torbjörn; Pettersson, David; Berglund, Åke et al.

Part of The Lancet Oncology, p. 336-346, 2017

• DOI for Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial

Need for adjuvant chemotherapy after colon cancer surgery - has it decreased?

Boeckelman, Camilla; Glimelius, Bengt

Part of Acta Oncologica, p. 629-633, 2017

• DOI for Need for adjuvant chemotherapy after colon cancer surgery - has it decreased?

Development of anxiety, depression and health-related quality of life in oncology patients without initial symptoms according to the Hospital Anxiety and Depression Scale – a comparative study

Thalén Lindström, Annika; Glimelius, Bengt; Johansson, Birgitta

Part of Acta Oncologica, p. 1094-1102, 2017

• DOI for Development of anxiety, depression and health-related quality of life in oncology patients without initial symptoms according to the Hospital Anxiety and Depression Scale – a comparative study

Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study

Guren, Tormod Kyrre; Thomsen, Maria; Kure, Elin H.; Sorbye, Halfdan et al.

Part of British Journal of Cancer, p. 1271-1278, 2017

• DOI for Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study
• Download full text (pdf) of Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study

Lymphovascular and perineural invasion in stage II rectal cancer: a report from the Swedish colorectal cancer registry

Nikberg, Maziar; Chabok, Abbas; Letocha, Henry; Kindler, Csaba et al.

Part of Acta Oncologica, p. 1418-1424, 2016

• DOI for Lymphovascular and perineural invasion in stage II rectal cancer: a report from the Swedish colorectal cancer registry

ESPAC-4: A Multicenter, International, Randomized Controlled Phase III Trial of Adjuvant Combination Chemotherapy of Gemcitabine (GEM) and Capecitabine (CAP), Versus Monotherapy Gemcitabine in Patients With Resected Pancreatic Ductal Adenocarcinoma

Neoptolemos, J. P.; Palmer, D.; Ghaneh, P.; Valle, J. et al.

Part of Pancreas, p. 1529-1529, 2016

Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes

Machiela, Mitchell J.; Lan, Qing; Slager, Susan L.; Vermeulen, Roel C. H. et al.

Part of Human Molecular Genetics, p. 1663-1676, 2016

• DOI for Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes

TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: A potential novel approach to the treatment of metastatic colorectal cancer

Tarpgaard, Line S.; Orum-Madsen, Maj Sofie; Christensen, Ib J.; Nordgaard, Cathrine et al.

Part of Oncotarget, p. 59441-59457, 2016

• DOI for TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: A potential novel approach to the treatment of metastatic colorectal cancer

Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer

Mezheyeuski, Artur; Lindh, Maja Bradic; Guren, Tormod Kyrre; Dragomir, Anca et al.

Part of Oncotarget, p. 41948-41958, 2016

• DOI for Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer

Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer

Thomsen, Maria; Kersten, Christian; Sorbye, Halfdan; Skovlund, Eva et al.

Part of Oncotarget, p. 75013-75022, 2016

• DOI for Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer

Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia

Berndt, Sonja I.; Camp, Nicola J.; Skibola, Christine F.; Vijai, Joseph et al.

Part of Nature Communications, 2016

• DOI for Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia
• Download full text (pdf) of Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia

Image analysis-derived metrics of histomorphological complexity predicts prognosis and treatment response in stage II-III colon cancer

Mezheyeuski, Artur; Hrynchyk, Ina; Karlberg, Mia; Portyanko, Anna et al.

Part of Scientific Reports, 2016

• DOI for Image analysis-derived metrics of histomorphological complexity predicts prognosis and treatment response in stage II-III colon cancer
• Download full text (pdf) of Image analysis-derived metrics of histomorphological complexity predicts prognosis and treatment response in stage II-III colon cancer

Detection of prognostic biomarkers with solid-phase proximity ligation assay in patients with colorectal cancer

Ghanipour, Lana; Darmanis, Spyros; Landegren, Ulf; Glimelius, Bengt et al.

Part of Translational Oncology, p. 251-255, 2016

• DOI for Detection of prognostic biomarkers with solid-phase proximity ligation assay in patients with colorectal cancer
• Download full text (pdf) of Detection of prognostic biomarkers with solid-phase proximity ligation assay in patients with colorectal cancer

Identification of distress in oncology patients: a comparison of the Hospital Anxiety and Depression Scale and a thorough clinical assessment

Thalén-Lindström, Annika; Glimelius, Bengt; Johansson, Birgitta

Part of Cancer Nursing, 2016

• DOI for Identification of distress in oncology patients: a comparison of the Hospital Anxiety and Depression Scale and a thorough clinical assessment

Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: A randomised trial

Cashin, Peter H.; Mahteme, Haile; Spang, N.; Syk, I. et al.

Part of European Journal of Cancer, p. 155-162, 2016

• DOI for Cytoreductive surgery and intraperitoneal chemotherapy versus systemic chemotherapy for colorectal peritoneal metastases: A randomised trial

Does shared decision making exist in oncologic practice?

Glimelius, Bengt; Cavalli-Björkman, Nina

Part of Acta Oncologica, p. 125-128, 2016

• DOI for Does shared decision making exist in oncologic practice?

What is most relevant in preoperative rectal cancer chemoradiotherapy - the chemotherapy, the radiation dose or the timing to surgery?

Glimelius, Bengt

Part of Acta Oncologica, p. 1381-1385, 2016

• DOI for What is most relevant in preoperative rectal cancer chemoradiotherapy - the chemotherapy, the radiation dose or the timing to surgery?

NORDIC9: A randomized phase II trial exploring treatment of older patients with metastatic colorectal cancer (mCRC) by comparing full dose monotherapy (S-1 followed by irinotecan) with reduced combination regimen (S-1/oxaliplatin followed by S-1/irinotecan)

Winther, S. B.; Osterlund, P.; Berglund, Åke; Glimelius, Bengt et al.

Part of Annals of Oncology, 2016

• DOI for NORDIC9: A randomized phase II trial exploring treatment of older patients with metastatic colorectal cancer (mCRC) by comparing full dose monotherapy (S-1 followed by irinotecan) with reduced combination regimen (S-1/oxaliplatin followed by S-1/irinotecan)

KRAS mutations in circulating tumour DNA (ctDNA) in MRI-defined, high-risk, locally-advanced rectal cancer (LARC) patients (pts) from the EXPERT-C trial

Sclafani, F.; Chau, I.; Cunningham, D.; Vlachogiannis, G. et al.

Part of Annals of Oncology, 2016

• DOI for KRAS mutations in circulating tumour DNA (ctDNA) in MRI-defined, high-risk, locally-advanced rectal cancer (LARC) patients (pts) from the EXPERT-C trial

Two countries - Two treatment strategies for rectal cancer

Glimelius, Bengt; Myklebust, Tor Åge; Lundqvist, Kristina; Wibe, Arne et al.

Part of Radiotherapy and Oncology, p. 357-363, 2016

• DOI for Two countries - Two treatment strategies for rectal cancer

Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients

Sclafani, Francesco; Chau, Ian; Cunningham, David; Lampis, Andrea et al.

Part of Carcinogenesis, p. 852-857, 2016

• DOI for Sequence variation in mature microRNA-608 and benefit from neo-adjuvant treatment in locally advanced rectal cancer patients

Impact of pre-treatment patient-related selection parameters on outcome in rectal cancer

Elliot, A. H.; Martling, A.; Glimelius, Bengt; Johansson, H. et al.

Part of European Journal of Surgical Oncology, p. 1667-1673, 2016

• DOI for Impact of pre-treatment patient-related selection parameters on outcome in rectal cancer

PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer

Sclafani, F.; Brown, G.; Cunningham, D.; Wotherspoon, A. et al.

Part of Annals of Oncology, p. 1557-1565, 2016

• DOI for PAN-EX: a pooled analysis of two trials of neoadjuvant chemotherapy followed by chemoradiotherapy in MRI-defined, locally advanced rectal cancer

Tell all the good news as soon as possible

Glimelius, Bengt

Part of Acta Oncologica, p. 1067-1068, 2016

• DOI for Tell all the good news as soon as possible

Further Evaluating the Benefit of Adjuvant Chemotherapy for Colon Cancer Reply

Glimelius, Bengt; Hohenberger, Werner Max; Matzel, Klaus E.; Sugihara, Kenichi et al.

Part of Journal of Clinical Oncology, p. 3713-+, 2016

• DOI for Further Evaluating the Benefit of Adjuvant Chemotherapy for Colon Cancer Reply

Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial

Hammel, Pascal; Huguet, Florence; van Laethem, Jean-Luc; Goldstein, David et al.

Part of Journal of the American Medical Association (JAMA), p. 1844-1853, 2016

• DOI for Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial

Should the Benefit of Adjuvant Chemotherapy in Colon Cancer Be Re-Evaluated?

Påhlman, Lars A.; Hohenberger, Werner M.; Matzel, Klaus; Sugihara, Kenichi et al.

Part of Journal of Clinical Oncology, p. 1297-+, 2016

• DOI for Should the Benefit of Adjuvant Chemotherapy in Colon Cancer Be Re-Evaluated?

Eight Cycles of ABVD Versus Four Cycles of BEACOPP(escalated) Plus Four Cycles of BEACOPP(baseline) in Stage III to IV, International Prognostic Score >= 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial

Carde, Patrice; Karrasch, Matthias; Fortpied, Catherine; Brice, Pauline et al.

Part of Journal of Clinical Oncology, p. 2028-+, 2016

• DOI for Eight Cycles of ABVD Versus Four Cycles of BEACOPP(escalated) Plus Four Cycles of BEACOPP(baseline) in Stage III to IV, International Prognostic Score >= 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial

Any progress in pancreatic cancer?

Glimelius, Bengt

Part of Acta Oncologica, p. 255-258, 2016

• DOI for Any progress in pancreatic cancer?

Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP)

Vernerey, Dewi; Huguet, Florence; Vienot, Angelique; Goldstein, David et al.

Part of British Journal of Cancer, p. 281-289, 2016

• DOI for Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP)

Healthcare Use Among Young Hodgkin Lymphoma Survivors In The Era Of Intensified Chemotherapy And Limited Radiotherapy

Eloranta, S.; Smedby, K. E.; Ekberg, S.; Chang, E. et al.

Part of Haematologica, p. 64-65, 2016

Hodgkin Lymphoma In Children, Adolescents And Young Adults-A Comparative Study Of Clinical Presentation And Treatment Outcome

Englund, Annika; Glimelius, Bengt; Rostgaard, K.; Eloranta, S. et al.

Part of Haematologica, p. 36-36, 2016

Potential value of immunoscoring in rectal cancer patients

Glimelius, Bengt

Part of TRANSLATIONAL CANCER RESEARCH, p. 94-97, 2016

• DOI for Potential value of immunoscoring in rectal cancer patients

Autoimmune and Atopic Disorders and Risk of Classical Hodgkin Lymphoma

Hollander, Peter; Rostgaard, Klaus; Smedby, Karin E.; Chang, Ellen T. et al.

Part of American Journal of Epidemiology, p. 624-632, 2015

• DOI for Autoimmune and Atopic Disorders and Risk of Classical Hodgkin Lymphoma

Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer

Birgisson, Helgi; Edlund, Karolina; Wallin, Ulrik; Påhlman, Lars et al.

Part of BMC Cancer, 2015

• DOI for Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer
• Download full text (pdf) of Microsatellite instability and mutations in BRAF and KRAS are significant predictors of disseminated disease in colon cancer

A genome-wide association study of marginal zone lymphoma shows association to the HLA region

Vijai, Joseph; Wang, Zhaoming; Berndt, Sonja I.; Skibola, Christine F. et al.

Part of Nature Communications, 2015

• DOI for A genome-wide association study of marginal zone lymphoma shows association to the HLA region
• Download full text (pdf) of A genome-wide association study of marginal zone lymphoma shows association to the HLA region

High BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumor Tissue Availability in a Prospective Population-Based Metastatic Colorectal Cancer Cohort

Sorbye, Halfdan; Dragomir, Anca; Sundström, Magnus; Pfeiffer, Per et al.

Part of PLOS ONE, 2015

• DOI for High BRAF Mutation Frequency and Marked Survival Differences in Subgroups According to KRAS/BRAF Mutation Status and Tumor Tissue Availability in a Prospective Population-Based Metastatic Colorectal Cancer Cohort

Toxicity and quality of life data from SCOT: An international phase III randomized (1:1) noninferiority trial comparing 3 vs 6 months of oxaliplatin-based adjuvant chemotherapy.

Iveson, Timothy; Kerr, Rachel; Saunders, Mark P.; Waterston, Ashita Marie et al.

Part of Journal of Clinical Oncology, 2015

Is the benefit of oxaliplatin in rectal cancer clinically relevant?

Glimelius, Bengt

Part of The Lancet Oncology, p. 883-885, 2015

• DOI for Is the benefit of oxaliplatin in rectal cancer clinically relevant?

C-reactive protein and interleukin-6 as markers of systemic inflammatory response and as prognostic factors for metastatic colorectal cancer. Data from the randomized phase III NORDIC-VII study

Thomsen, Maria; Kersten, Christian; Sorbye, Halfdan; Skovlund, Eva et al.

Part of Journal of Clinical Oncology, 2015

Time trends, improvements and national auditing of rectal cancer management over an 18-year period

Kodeda, K.; Johansson, R.; Zar, N.; Birgisson, Helgi et al.

Part of Colorectal Disease, 2015

• DOI for Time trends, improvements and national auditing of rectal cancer management over an 18-year period

Maintenance Therapy With Cetuximab Every Second Week in the First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-7.5 Study by the Nordic Colorectal Cancer Biomodulation Group

Pfeiffer, Per; Sorbye, Hafdan; Qvortrup, Camilla; Karlberg, Mia et al.

Part of Clinical colorectal cancer, p. 170-176, 2015

• DOI for Maintenance Therapy With Cetuximab Every Second Week in the First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-7.5 Study by the Nordic Colorectal Cancer Biomodulation Group

Chemotherapy or Liver Transplantation for Nonresectable Liver Metastases From Colorectal Cancer?

Dueland, Svein; Guren, Tormod K.; Hagness, Morten; Glimelius, Bengt et al.

Part of Annals of Surgery, p. 956-960, 2015

• DOI for Chemotherapy or Liver Transplantation for Nonresectable Liver Metastases From Colorectal Cancer?

Adjuvant chemotherapy for patients with rectal cancer - will the controversy be resolved?

Glimelius, Bengt

Part of Acta Oncologica, p. 433-436, 2015

• DOI for Adjuvant chemotherapy for patients with rectal cancer - will the controversy be resolved?

Tumour regression in the randomized Stockholm III Trial ofradiotherapy regimens for rectal cancer

Pettersson, D.; Loerinc, E.; Holm, T.; Iversen, H. et al.

Part of British Journal of Surgery, p. 972-978, 2015

• DOI for Tumour regression in the randomized Stockholm III Trial ofradiotherapy regimens for rectal cancer
• Download full text (pdf) of Tumour regression in the randomized Stockholm III Trial ofradiotherapy regimens for rectal cancer

Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial

Breugom, A. J.; van Gijn, W.; Muller, E. W.; Berglund, Åke et al.

Part of Annals of Oncology, p. 696-701, 2015

• DOI for Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial

A template for writing radiotherapy protocols

Nilsson, Per; Ceberg, Crister; Kjellen, Elisabeth; Gagliardi, Giovanna et al.

Part of Acta Oncologica, p. 275-279, 2015

• DOI for A template for writing radiotherapy protocols

Prognostic effect of a single nucleotide polymorphism (SNP) in MIR608 in patients with high-risk locally advanced rectal cancer (LARC): Results of the EXPERT-C trial.

Sclafani, Francesco; Chau, Ian; Cunningham, David; Lampis, Andrea et al.

Part of Journal of Clinical Oncology, 2015

Prognosis model for overall survival in locally advanced unresecable pancreatic carcinoma: An ancillary study of the LAP 07 trial

Vernerey, Dewi; Hammel, Pascal; Paget-Bailly, Sophie; Huguet, Florence et al.

Part of Journal of Clinical Oncology, 2015

The evolution of radiotherapy techniques in the management of prostate cancer

Hoyer, Morten; Muren, Ludvig P.; Glimelius, Bengt

Part of Acta Oncologica, p. 821-824, 2015

• DOI for The evolution of radiotherapy techniques in the management of prostate cancer

Postoperative chemotherapy in patients with rectal cancer receiving preoperative radio(chemo)therapy: A meta-analysis of randomized trials comparing surgery +/- a fluoropyrimidine and surgery plus a fluoropyrimidine +/- oxaliplatin

Bujko, K.; Glimelius, Bengt; Valentini, V.; Michalski, W. et al.

Part of European Journal of Surgical Oncology, p. 713-723, 2015

• DOI for Postoperative chemotherapy in patients with rectal cancer receiving preoperative radio(chemo)therapy: A meta-analysis of randomized trials comparing surgery +/- a fluoropyrimidine and surgery plus a fluoropyrimidine +/- oxaliplatin

Is England closing the international gap in cancer survival?

Walters, Sarah; Benitez-Majano, Sara; Muller, Patrick; Coleman, Michel P. et al.

Part of British Journal of Cancer, p. 848-860, 2015

• DOI for Is England closing the international gap in cancer survival?
• Download full text (pdf) of Is England closing the international gap in cancer survival?

Short-and Long-Term Quality of Life and Bowel Function in Patients With MRI-Defined, High-Risk, Locally Advanced Rectal Cancer Treated With an Intensified Neoadjuvant Strategy in the Randomized Phase 2 EXPERT-C Trial

Sclafani, Francesco; Peckitt, Clare; Cunningham, David; Tait, Diana et al.

Part of International Journal of Radiation Oncology, Biology, Physics, p. 303-312, 2015

• DOI for Short-and Long-Term Quality of Life and Bowel Function in Patients With MRI-Defined, High-Risk, Locally Advanced Rectal Cancer Treated With an Intensified Neoadjuvant Strategy in the Randomized Phase 2 EXPERT-C Trial

Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trial

Sclafani, F.; Chau, I.; Cunningham, D.; Peckitt, C. et al.

Part of Annals of Oncology, p. 1936-1941, 2015

• DOI for Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trial
• Download full text (pdf) of Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trial

Intact and cleaved plasma soluble urokinase receptor in patients with metastatic colorectal cancer treated with oxaliplatin with or without cetuximab

Tarpgaard, Line S.; Christensen, Ib J.; Hoyer-Hansen, Gunilla; Lund, Ida K. et al.

Part of International Journal of Cancer, p. 2470-2477, 2015

• DOI for Intact and cleaved plasma soluble urokinase receptor in patients with metastatic colorectal cancer treated with oxaliplatin with or without cetuximab

Prognostic role of the LCS-6 KRAS variant in locally advanced rectal cancer: Results of the EXPERT-C trial

Sclafani, F.; Chau, I.; Cunningham, D.; Peckitt, C. et al.

Part of European Journal of Cancer, 2015

What's new about Acta Oncologica for 2016?

Glimelius, Bengt

Part of Acta Oncologica, p. 1703-1705, 2015

• DOI for What's new about Acta Oncologica for 2016?

Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for 13 Cancer Types

Sampson, Joshua N.; Wheeler, William A.; Yeager, Meredith; Panagiotou, Orestis et al.

Part of Journal of the National Cancer Institute, 2015

• DOI for Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for 13 Cancer Types

O-15-Water PET Study of the Effect of Imatinib, a Selective Platelet-Derived Growth Factor Receptor Inhibitor, Versus Anakinra, an IL-1R Antagonist, on Water-Perfusable Tissue Fraction in Colorectal Cancer Metastases

Lubberink, Mark; Golla, Sanjeep S. V.; Jonasson, My; Rubin, Kristofer et al.

Part of Journal of Nuclear Medicine, p. 1144-1149, 2015

• DOI for O-15-Water PET Study of the Effect of Imatinib, a Selective Platelet-Derived Growth Factor Receptor Inhibitor, Versus Anakinra, an IL-1R Antagonist, on Water-Perfusable Tissue Fraction in Colorectal Cancer Metastases

A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus

Cozen, W.; Timofeeva, M. N.; Li, D.; Diepstra, A. et al.

Part of Nature Communications, p. 3856, 2014

• DOI for A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus

Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region

Skibola, Christine F.; Berndt, Sonja I.; Vijai, Joseph; Conde, Lucia et al.

Part of American Journal of Human Genetics, p. 462-471, 2014

• DOI for Genome-wide Association Study Identifies Five Susceptibility Loci for Follicular Lymphoma outside the HLA Region

Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma

Cerhan, James R.; Berndt, Sonja I.; Vijai, Joseph; Ghesquieres, Herve et al.

Part of Nature Genetics, p. 1233-1238, 2014

• DOI for Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma

A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancer

Lindskog, Elinor Bexe; Gunnarsdottir, Katrin Asta; Derwinger, Kristoffer; Wettergren, Yvonne et al.

Part of BMC Cancer, p. 948, 2014

• DOI for A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancer
• Download full text (pdf) of A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancer

1p36 deletion is a marker for tumour dissemination in microsatellite stable stage II-III colon cancer

Mayrhofer, Markus; Kultima, Hanna Göransson; Birgisson, Helgi; Sundström, Magnus et al.

Part of BMC Cancer, p. 872, 2014

• DOI for 1p36 deletion is a marker for tumour dissemination in microsatellite stable stage II-III colon cancer
• Download full text (pdf) of 1p36 deletion is a marker for tumour dissemination in microsatellite stable stage II-III colon cancer

Comparison of two instruments for measurement of quality of life in clinical practice - a qualitative study

Wettergren, Lena; Lindberg, Mathilde Hedlund; Kettis, Åsa; Glimelius, Bengt et al.

Part of BMC Medical Research Methodology, p. 115, 2014

• DOI for Comparison of two instruments for measurement of quality of life in clinical practice - a qualitative study
• Download full text (pdf) of Comparison of two instruments for measurement of quality of life in clinical practice - a qualitative study

A comprehensive evaluation of the role of genetic variation in follicular lymphoma survival

Baecklund, Fredrik; Foo, Jia-Nee; Bracci, Paige; Darabi, Hatef et al.

Part of BMC Medical Genetics, p. 113, 2014

• DOI for A comprehensive evaluation of the role of genetic variation in follicular lymphoma survival
• Download full text (pdf) of A comprehensive evaluation of the role of genetic variation in follicular lymphoma survival

Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-Analysis

Rosmarin, Dan; Palles, Claire; Church, David; Domingo, Enric et al.

Part of Journal of Clinical Oncology, p. 1031-1039, 2014

• DOI for Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-Analysis

Plasma YKL-40 in Patients with Metastatic Colorectal Cancer Treated with First Line Oxaliplatin-Based Regimen with or without Cetuximab: RESULTS from the NORDIC VII Study

Tarpgaard, Line S.; Guren, Tormod K.; Glimelius, Bengt; Christensen, Ib J. et al.

Part of PLOS ONE, 2014

• DOI for Plasma YKL-40 in Patients with Metastatic Colorectal Cancer Treated with First Line Oxaliplatin-Based Regimen with or without Cetuximab: RESULTS from the NORDIC VII Study
• Download full text (pdf) of Plasma YKL-40 in Patients with Metastatic Colorectal Cancer Treated with First Line Oxaliplatin-Based Regimen with or without Cetuximab: RESULTS from the NORDIC VII Study

Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells.

Häggblad Sahlberg, Sara; Spiegelberg, Diana; Glimelius, Bengt; Stenerlöw, Bo et al.

Part of PLOS ONE, 2014

• DOI for Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells.
• Download full text (pdf) of Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells.

Clinical Benefit Response in Pancreatic Cancer Trials Revisited

Bernhard, Juerg; Dietrich, Daniel; Glimelius, Bengt; Bodoky, Gyoergy et al.

Part of Oncology Research and Treatment, p. 42-48, 2014

• DOI for Clinical Benefit Response in Pancreatic Cancer Trials Revisited

EURECCA colorectal: Multidisciplinary management: European consensus conference colon & rectum

van de Velde, Cornelis J. H.; Boelens, Petra G.; Borras, Josep M.; Coebergh, Jan-Willem et al.

Part of European Journal of Cancer, 2014

• DOI for EURECCA colorectal: Multidisciplinary management: European consensus conference colon & rectum

The 50-year anniversary of Acta Oncologica

Glimelius, Bengt

Part of Acta Oncologica, p. 1-2, 2014

• DOI for The 50-year anniversary of Acta Oncologica

Cost-utility analysis of individual psychosocial support interventions for breast cancer patients in a randomized controlled study

Arving, Cecilia; Brandberg, Yvonne; Feldman, Inna; Johansson, Birgitta et al.

Part of Psycho-Oncology, p. 251-258, 2014

• DOI for Cost-utility analysis of individual psychosocial support interventions for breast cancer patients in a randomized controlled study

Comparison of ColoPrint risk classification with clinical risk in the prospective PARSC trial

Salazar, Ramon; Capdevila, Jaume; Rosenberg, Robert; de Waard, Jan Willem et al.

Part of Journal of Clinical Oncology, 2014

The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysis

Dias, M M; Pignon, J-P; Karapetis, C S; Boige, V et al.

Part of The Pharmacogenomics Journal, p. 424-431, 2014

• DOI for The effect of the UGT1A1*28 allele on survival after irinotecan-based chemotherapy: a collaborative meta-analysis

Liver Transplantation or Chemotherapy for Non-Resectable Colorectal Liver Metastases?

Hagness, M.; Guren, T.; Glimelius, Bengt; Pfeiffer, P. et al.

Part of American Journal of Transplantation, p. 166-166, 2014

Liver Transplantation or Chemotherapy for Non-Resectable Colorectal Liver Metastases?

Hagness, M.; Guren, T.; Glimelius, Bengt; Pfeiffer, P. et al.

Part of Transplantation, p. 166-166, 2014

Fc gamma RIIa and Fc gamma RIIIa Polymorphisms and Cetuximab Benefit in the Microscopic Disease

Sclafani, Francesco; de Castro, David Gonzalez; Cunningham, David; Wilson, Sanna Hulkki et al.

Part of Clinical Cancer Research, p. 4511-4519, 2014

• DOI for Fc gamma RIIa and Fc gamma RIIIa Polymorphisms and Cetuximab Benefit in the Microscopic Disease

TP53 Mutational Status and Cetuximab Benefit in Rectal Cancer: 5-Year Results of the EXPERT-C Trial

Sclafani, Francesco; Gonzalez, David; Cunningham, David; Wilson, Sanna Hulkki et al.

Part of Journal of the National Cancer Institute, 2014

• DOI for TP53 Mutational Status and Cetuximab Benefit in Rectal Cancer: 5-Year Results of the EXPERT-C Trial

Adjuvant chemotherapy for rectal cancer still controversial

Beets, Geerard L.; Glimelius, Bengt

Part of The Lancet Oncology, p. 130-131, 2014

• DOI for Adjuvant chemotherapy for rectal cancer still controversial

Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial

Greenhalf, William; Ghaneh, Paula; Neoptolemos, John P.; Palmer, Daniel H. et al.

Part of Journal of the National Cancer Institute, 2014

• DOI for Pancreatic Cancer hENT1 Expression and Survival From Gemcitabine in Patients From the ESPAC-3 Trial

The influence of AKT isoforms on radiation sensitivity and DNA repair in colon cancer cell lines

Häggblad Sahlberg, Sara; Gustafsson, Ann-Sofie; Pendekanti, Prathyusha N.; Glimelius, Bengt et al.

Part of Tumor Biology, p. 3525-3534, 2014

• DOI for The influence of AKT isoforms on radiation sensitivity and DNA repair in colon cancer cell lines
• Download full text (pdf) of The influence of AKT isoforms on radiation sensitivity and DNA repair in colon cancer cell lines

Adjuvant chemotherapy for rectal cancer

Bujko, Krzysztof; Glimelius, Bengt

Part of The Lancet Oncology, 2014

• DOI for Adjuvant chemotherapy for rectal cancer

RAS mutations and cetuximab in locally advanced rectal cancer: Results of the EXPERT-C trial

Sclafani, F.; Gonzalez, D.; Cunningham, D.; Wilson, S. Hulkki et al.

Part of European Journal of Cancer, p. 1430-1436, 2014

• DOI for RAS mutations and cetuximab in locally advanced rectal cancer: Results of the EXPERT-C trial

Quality of life in patients with advanced gastric cancer sequentially treated with docetaxel and irinotecan with 5-fluorouracil and folinic acid (leucovin)

Gubanski, M.; Glimelius, Bengt; Lind, P. A.

Part of Medical Oncology, p. 906, 2014

• DOI for Quality of life in patients with advanced gastric cancer sequentially treated with docetaxel and irinotecan with 5-fluorouracil and folinic acid (leucovin)

Outcome after liver transplantation compared with chemotherapy in colorectal cancer patients with nonresectable liver-only disease.

Dueland, Svein; Kyrre, Tormod; Hagness, Guren Morten; Glimelius, Bengt et al.

Part of Journal of Clinical Oncology, 2014

Relationship of RAS and TP53 predictive value for cetuximab (C) benefit: Results of the EXPERT-C trial

Sclafani, Francesco; Gonzalez, David; Cunningham, David; Wilson, Sanna Hullki et al.

Part of Journal of Clinical Oncology, 2014

RAS mutations in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab (C) in MRI-defined, high-risk rectal cancer (RC).

Sclafani, Francesco; Gonzalez, David; Cunningham, David; Wilson, Sanna Hullki et al.

Part of Journal of Clinical Oncology, 2014

Acta Oncologica and a new generation of scientists in oncology

Glimelius, Bengt; Johansen, Christoffer; Muren, Ludvig Paul; Nilbert, Mef

Part of Acta Oncologica, p. 849-851, 2014

• DOI for Acta Oncologica and a new generation of scientists in oncology

Preoperative treatment selection in rectal cancer: A population-based cohort study

Elliot, A. H.; Martling, A.; Glimelius, Bengt; Nordenvall, C. et al.

Part of European Journal of Surgical Oncology, p. 1782-1788, 2014

• DOI for Preoperative treatment selection in rectal cancer: A population-based cohort study

QOL assessments in clinical practice: usefulness of ERORTC-QLQC-30 and the SEIOQL

Ring, Lena; Wettergren, Lena; Fagerlind, Hanna; Glimelius, Bengt et al.

Part of Quality of Life Research, p. 104-104, 2014

Benefit of EGFR-inhibition therapy for metastatic colorectal cancer patients with KRAS-mutated tumors and high plasma TIMP-I level: Results from the NORDIC VII study

Brunner, Nils; Tarpgaard, Line Schmidt; Christensen, Ib Jarle; Moreira, Jose et al.

Part of Journal of Clinical Oncology, 2014

Digitalized multiparametric analyses of tumor stroma for identification of low perivascular PDGFBR expression and low vessel density as independent prognosis markers for stage IV CRC

Mezheyeuski, Artur; Lindh, Maja Bradic; Glimelius, Bengt; Pfeiffer, Per et al.

Part of Journal of Clinical Oncology, 2014

Panex: A pooled analysis of EXPERT and EXPERT-C, two trials of neoadjuvant chemotherapy (NACT) and chemoradiotherapy (CRT) in high-risk locally advanced rectal cancer (LARC)

Sclafani, Francesco; Peckitt, Clare; Cunningham, David; Evans, Jessica et al.

Part of Journal of Clinical Oncology, 2014

FC gamma RIIa and FC gamma RIIa polymorphisms (SNPs) and cetuximab (C) benefit in the EXPERT-C trial

Sclafani, Francesco; Gonzalez de Castro, David; Cunningham, David; Wilson, Sanna Hulkki et al.

Part of Journal of Clinical Oncology, 2014

Comparison of ColoPrint risk classification with clinical risk in the prospective PARSC trial

Salazar, Ramon; Capdevila, Jaume; Rosenberg, Robert; Glimelius, Bengt et al.

Part of Journal of Clinical Oncology, 2014

Patients with rectal cancer receiving adjuvant chemotherapy have an increased survival: a population-based longitudinal study

Tiselius, C; Gunnarsson, U; Smedh, Kennet; Glimelius, Bengt et al.

Part of Annals of Oncology, p. 160-165, 2013

• DOI for Patients with rectal cancer receiving adjuvant chemotherapy have an increased survival: a population-based longitudinal study

Barriers against psychosocial communication: Oncologists' perceptions

Fagerlind, Hanna; Kettis, Åsa; Glimelius, Bengt; Ring, Lena

Part of Journal of Clinical Oncology, 2013

• DOI for Barriers against psychosocial communication: Oncologists' perceptions

Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer - the RAPIDO trial

Nilsson, Per J.; van Etten, Boudewijn; Hospers, Geke A. P.; Påhlman, Lars et al.

Part of BMC Cancer, p. 279, 2013

• DOI for Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer - the RAPIDO trial
• Download full text (pdf) of Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer - the RAPIDO trial

Integrated peripheral boost in preoperative radiotherapy for the locally most advanced non-resectable rectal cancer patients

Radu, Calin; Norrlid, Ola; Braendengen, Morten; Hansson, Karl et al.

Part of Acta Oncologica, p. 528-537, 2013

• DOI for Integrated peripheral boost in preoperative radiotherapy for the locally most advanced non-resectable rectal cancer patients

Phase II study of patients with peritoneal carcinomatosis from gastric cancer treated with preoperative systemic chemotherapy followed by peritonectomy and intraperitoneal chemotherapy

Hultman, Bo; Lind, Pehr; Glimelius, Bengt; Sundbom, Magnus et al.

Part of Acta Oncologica, p. 824-830, 2013

• DOI for Phase II study of patients with peritoneal carcinomatosis from gastric cancer treated with preoperative systemic chemotherapy followed by peritonectomy and intraperitoneal chemotherapy

Validation of the Distress Thermometer in a Swedish population of oncology patients: accuracy of changes during six months

Thalén-Lindström, Annika; Larsson, Gunnel; Hellbom, Maria; Glimelius, Bengt et al.

Part of European Journal of Oncology Nursing, p. 625-631, 2013

• DOI for Validation of the Distress Thermometer in a Swedish population of oncology patients: accuracy of changes during six months

Anxiety and depression in oncology patients: a longitudinal study of a screening, assessment and psychosocial support intervention

Thalén-Lindström, Annika; Larsson, Gunnel; Glimelius, Bengt; Johansson, Birgitta

Part of Acta Oncologica, p. 118-127, 2013

• DOI for Anxiety and depression in oncology patients: a longitudinal study of a screening, assessment and psychosocial support intervention

Neo-adjuvant radiotherapy in rectal cancer

Glimelius, Bengt

Part of World Journal of Gastroenterology, p. 8489-8501, 2013

• DOI for Neo-adjuvant radiotherapy in rectal cancer

HER2 in high-risk rectal cancer patients treated in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab

Sclafani, F.; Roy, A.; Cunningham, D.; Wotherspoon, A. et al.

Part of Annals of Oncology, p. 3123-3128, 2013

• DOI for HER2 in high-risk rectal cancer patients treated in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab

Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia

Berndt, Sonja I.; Skibola, Christine F.; Joseph, Vijai; Camp, Nicola J. et al.

Part of Nature Genetics, p. 868-U202, 2013

• DOI for Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia

Coding Variants at Hexa-allelic Amino Acid 13 of HLA-DRB1 Explain Independent SNP Associations with Follicular Lymphoma Risk

Foo, Jia Nee; Smedby, Karin E.; Akers, Nicholas K.; Berglund, Mattias et al.

Part of American Journal of Human Genetics, p. 167-172, 2013

• DOI for Coding Variants at Hexa-allelic Amino Acid 13 of HLA-DRB1 Explain Independent SNP Associations with Follicular Lymphoma Risk

Population-based data from the Swedish Colon Cancer Registry

Kodeda, K.; Nathanaelsson, L.; Jung, B.; Olsson, H. et al.

Part of British Journal of Surgery, p. 1100-1107, 2013

• DOI for Population-based data from the Swedish Colon Cancer Registry

Impaired postoperative leucocyte counts after preoperative radiotherapy for rectal cancer in the Stockholm III Trial

Pettersson, D.; Glimelius, Bengt; Iversen, H.; Johansson, H. et al.

Part of British Journal of Surgery, p. 969-U145, 2013

• DOI for Impaired postoperative leucocyte counts after preoperative radiotherapy for rectal cancer in the Stockholm III Trial

The rise and fall of a longed for clinical trial in patients with generalized colorectal cancer

Arbman, Gunnar; Påhlman, Lars; Glimelius, Bengt

Part of Acta Oncologica, p. 1779-1782, 2013

• DOI for The rise and fall of a longed for clinical trial in patients with generalized colorectal cancer

What is the appropriate use of palliative docetaxel in castration-resistant prostate cancer?

Steineck, Gunnar; Glimelius, Bengt

Part of Acta Oncologica, p. 1589-1592, 2013

• DOI for What is the appropriate use of palliative docetaxel in castration-resistant prostate cancer?

50 years with Acta Oncologica

Glimelius, Bengt

Part of Acta Oncologica, p. 1-2, 2013

• DOI for 50 years with Acta Oncologica

Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Glimelius, Bengt; Tiret, E.; Cervantes, A.; Arnold, D.

Part of Annals of Oncology, p. 81-88, 2013

• DOI for Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Age-dependent improvement in median and long-term survival in unselected population-based Nordic registries of patients with synchronous metastatic colorectal cancer

Sorbye, H.; Cvancarova, M.; Qvortrup, C.; Pfeiffer, P. et al.

Part of Annals of Oncology, p. 2354-2360, 2013

• DOI for Age-dependent improvement in median and long-term survival in unselected population-based Nordic registries of patients with synchronous metastatic colorectal cancer

Potentials of high resolution magnetic resonance imaging versus computed tomography for preoperative local staging of colon cancer

Rollven, Erik; Holm, Torbjorn; Glimelius, Bengt; Lorinc, Esther et al.

Part of Acta Radiologica, p. 722-730, 2013

• DOI for Potentials of high resolution magnetic resonance imaging versus computed tomography for preoperative local staging of colon cancer

Investigation of Relation of Radiation Therapy Quality Assurance Scores (RTQASc) With Toxicity and Survival in LAP07 Phase 3 Trial for Locally Advanced Pancreatic Carcinoma (LAPC)

Huguet, F.; Racadot, S.; Goldstein, D.; Spry, N. et al.

Part of International Journal of Radiation Oncology, Biology, Physics, 2013

Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

Nordlinger, Bernard; Sorbye, Halfdan; Glimelius, Bengt; Poston, Graeme J. et al.

Part of The Lancet Oncology, p. 1208-1215, 2013

• DOI for Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial

Updated survival analysis of EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab in MRI-defined high risk rectal cancer patients

Sclafani, F.; Cunningham, D.; Tabernero, J.; Glimelius, Bengt et al.

Part of European Journal of Cancer, 2013

Establishing and expanding the indications for proton and particle therapy

Muren, Ludvig P.; Rossi, Carl; Hug, Eugen; Lee, Andrew et al.

Part of Acta Oncologica, p. 459-462, 2013

• DOI for Establishing and expanding the indications for proton and particle therapy

Impact of the first tumor response at eight weeks on overall survival in metastatic breast cancer patients treated with first-line combination chemotherapy

Suzuki, Chikako; Blomqvist, Lennart; Hatschek, Thomas; Carlsson, Lena et al.

Part of Medical Oncology, p. 415, 2013

• DOI for Impact of the first tumor response at eight weeks on overall survival in metastatic breast cancer patients treated with first-line combination chemotherapy

Radiotherapy in rectal cancer - What have we learnt?

Glimelius, Bengt

Part of European Journal of Cancer, 2013

Lifestyle factors, autoimmune disease and family history in prognosis of non-hodgkin lymphoma overall and subtypes

Simard, Julia F; Baecklund, Fredrik; Chang, Ellen T; Baecklund, Eva et al.

Part of International Journal of Cancer, p. 2659-2666, 2013

• DOI for Lifestyle factors, autoimmune disease and family history in prognosis of non-hodgkin lymphoma overall and subtypes

Comparison of chemoradiotherapy (CRT) and chemotherapy (CT) in patients with a locally advanced pancreatic cancer (LAPC) controlled after 4 months of gemcitabine with or without erlotinib: Final results of the international phase III LAP 07 study

Hammel, Pascal; Huguet, Florence; Van Laethem, Jean-Luc; Goldstein, David et al.

Part of Journal of Clinical Oncology, 2013

EURECCA colorectal: Multidisciplinary Mission statement on better care for patients with colon and rectal cancer in Europe

van de Velde, Cornelis J. H.; Aristei, Cynthia; Boelens, Petra G.; Beets-Tan, Regina G. H. et al.

Part of European Journal of Cancer, p. 2784-2790, 2013

• DOI for EURECCA colorectal: Multidisciplinary Mission statement on better care for patients with colon and rectal cancer in Europe

Let-7 miRNA-binding site polymorphism in the KRAS 3`UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab.

Kjersem, Janne B; Ikdahl, Tone; Guren, Tormod; Skovlund, Eva et al.

Part of BMC Cancer, p. 534, 2012

• DOI for Let-7 miRNA-binding site polymorphism in the KRAS 3`UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab.
• Download full text (pdf) of Let-7 miRNA-binding site polymorphism in the KRAS 3`UTR; colorectal cancer screening population prevalence and influence on clinical outcome in patients with metastatic colorectal cancer treated with 5-fluorouracil and oxaliplatin +/- cetuximab.

Quality of life in peritoneal carcinomatosis after cytoreductive surgery and intraperitoneal chemotherapy

Hansson, Johan; Graf, Wilhelm; Nygren, Peter; Ring, Lena et al.

2012

Equal cancer treatment regardless of education level and family support?: A qualitative study of oncologists’ decision-making

Cavalli-Björkman, Nina; Glimelius, Bengt; Strang, Peter

Part of BMJ Open, 2012

• DOI for Equal cancer treatment regardless of education level and family support?: A qualitative study of oncologists’ decision-making

The effect of a dimeric Affibody molecule (ZEGFR:1907)2 targeting EGFR in combination with radiation in colon cancer cell lines

Häggblad Sahlberg, Sara; Spiegelberg, Diana; Lennartsson, Johan; Nygren, Peter et al.

Part of International Journal of Oncology, p. 176-184, 2012

• DOI for The effect of a dimeric Affibody molecule (ZEGFR:1907)2 targeting EGFR in combination with radiation in colon cancer cell lines
• Download full text (pdf) of The effect of a dimeric Affibody molecule (ZEGFR:1907)2 targeting EGFR in combination with radiation in colon cancer cell lines

Histopathological Classification of Pseudomyxoma Peritonei and the Prognostic Importance of PINCH Protein

Andreasson, Håkan; Wanders, Alkwin; Sun, Xiao-Feng; Willén, Roger et al.

Part of Anticancer Research, p. 1443-1448, 2012

Costs and clinical outcome of neoadjuvant systemic chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from gastric cancer

Hultman, Bo; Lundkvist, Jonas; Glimelius, Bengt; Nygren, Peter et al.

Part of Acta Oncologica, p. 112-121, 2012

• DOI for Costs and clinical outcome of neoadjuvant systemic chemotherapy followed by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from gastric cancer

Outcome differences between debulking surgery and cytoreductive surgery in patients with pseudomyxoma peritonei

Andréasson, Håkan; Graf, Wilhelm; Nygren, Peter; Glimelius, Bengt et al.

Part of European Journal of Surgical Oncology, p. 962-968, 2012

• DOI for Outcome differences between debulking surgery and cytoreductive surgery in patients with pseudomyxoma peritonei

Multidisciplinary treatment of patients with rectal cancer: Development during the past decades and plans for the future

Glimelius, Bengt

Part of Upsala Journal of Medical Sciences, p. 225-236, 2012

• DOI for Multidisciplinary treatment of patients with rectal cancer: Development during the past decades and plans for the future

Long term survival data from EORTC study 40983: Perioperative chemotherapy for resectable liver metastases from colorectal cancer

Nordlinger, Bernard; Sorbye, Halfdan; Glimelius, Bengt; Poston, Graeme John et al.

Part of Annals of Oncology, p. 18-18, 2012

• DOI for Long term survival data from EORTC study 40983: Perioperative chemotherapy for resectable liver metastases from colorectal cancer

Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma: The ESPAC-3 Periampullary Cancer Randomized Trial

Neoptolemos, John P.; Moore, Malcolm J.; Cox, Trevor F.; Valle, Juan W. et al.

Part of Journal of the American Medical Association (JAMA), p. 147-156, 2012

• DOI for Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma: The ESPAC-3 Periampullary Cancer Randomized Trial

Metastatic colorectal cancer: Current treatment and future options for improved survival : Medical approach - present status

Glimelius, Bengt; Cavalli-Bjorkman, Nina

Part of Scandinavian Journal of Gastroenterology, p. 296-314, 2012

• DOI for Metastatic colorectal cancer: Current treatment and future options for improved survival : Medical approach - present status

Quantitative accuracy of parametric myocardial and tumour blood flow images based on HYPR-LR-filtered dynamic [O-15]water PET

Golla, Sandeep; Sörensen, Jens; Kero, Tanja; Harms, H. et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, 2012

Intrapatient Cetuximab Dose Escalation in Metastatic Colorectal Cancer According to the Grade of Early Skin Reactions: The Randomized EVEREST Study

Van Cutsem, Eric; Tejpar, Sabine; Vanbeckevoort, Dirk; Peeters, Marc et al.

Part of Journal of Clinical Oncology, p. 2861-2868, 2012

• DOI for Intrapatient Cetuximab Dose Escalation in Metastatic Colorectal Cancer According to the Grade of Early Skin Reactions: The Randomized EVEREST Study

Different perspectives on communication quality and emotional functioning during routine oncology consultations

Fagerlind, Hanna; Kettis, Åsa; Bergström, Ida; Glimelius, Bengt et al.

Part of Patient Education and Counseling, p. 16-22, 2012

• DOI for Different perspectives on communication quality and emotional functioning during routine oncology consultations

Age dependent increase in median and long-term survival in 29 628 metastatic colorectal cancer (mcrc) scandinavian patients during the past two decades

Qvortrup, C.; Cvancarova, M.; Glimelius, Bengt; Pfeiffer, P. et al.

Part of Annals of Oncology, p. 188-188, 2012

Which Rectal Cancers Are Locally Advanced?

Glimelius, Bengt

Part of Oncology, p. 743-+, 2012

Multicenter Randomized Phase II Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer (EXPERT-C)

Dewdney, Alice; Cunningham, David; Tabernero, Josep; Capdevila, Jaume et al.

Part of Journal of Clinical Oncology, p. 1620-1627, 2012

• DOI for Multicenter Randomized Phase II Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer (EXPERT-C)

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

Schmoll, H. J.; Van Cutsem, E.; Stein, A.; Valentini, V. et al.

Part of Annals of Oncology, p. 2479-2516, 2012

• DOI for ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study

Tveit, Kjell Magne; Guren, Tormod; Glimelius, Bengt; Pfeiffer, Per et al.

Part of Journal of Clinical Oncology, p. 1755-1762, 2012

• DOI for Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII Study

Lower treatment intensity and poorer survival in metastatic colorectal cancer patients who live alone

Cavalli-Björkman, Nina; Qvortrup, Camilla; Sebjørnssen, Sigrunn; Pfeiffer, Per et al.

Part of British Journal of Cancer, p. 189-194, 2012

• DOI for Lower treatment intensity and poorer survival in metastatic colorectal cancer patients who live alone

Predictive Factors for the Benefit of Perioperative FOLFOX for Resectable Liver Metastasis in Colorectal Cancer Patients (EORTC Intergroup Trial 40983)

Sorbye, Halfdan; Mauer, Murielle; Gruenberger, Thomas; Glimelius, Bengt et al.

Part of Annals of Surgery, p. 534-539, 2012

• DOI for Predictive Factors for the Benefit of Perioperative FOLFOX for Resectable Liver Metastasis in Colorectal Cancer Patients (EORTC Intergroup Trial 40983)

Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer

Pettersson, D.; Holm, T.; Iversen, H.; Blomqvist, L. et al.

Part of British Journal of Surgery, p. 577-583, 2012

• DOI for Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer

Genome-Wide Association Study of Classical Hodgkin Lymphoma and Epstein-Barr Virus Status-Defined Subgroups

Urayama, Kevin Y.; Jarrett, Ruth F.; Hjalgrim, Henrik; Diepstra, Arjan et al.

Part of Journal of the National Cancer Institute, p. 240-253, 2012

• DOI for Genome-Wide Association Study of Classical Hodgkin Lymphoma and Epstein-Barr Virus Status-Defined Subgroups

The initial change in tumor size predicts response and survival in patients with metastatic colorectal cancer treated with combination chemotherapy

Suzuki, C; Blomqvist, L; Sundin, Anders; Jacobsson, H et al.

Part of Annals of Oncology, p. 948-954, 2012

• DOI for The initial change in tumor size predicts response and survival in patients with metastatic colorectal cancer treated with combination chemotherapy

Evaluation of predictive markers for patients with advanced colorectal cancer

Byström, Per; Berglund, Åke; Nygren, Peter; Wernroth, Lisa et al.

Part of Acta Oncologica, p. 849-859, 2012

• DOI for Evaluation of predictive markers for patients with advanced colorectal cancer

Health-related quality of life (HRQoL) after multimodal treatment for primarily non-resectable rectal cancer: Long-term results from a phase III study

Brændengen, Morten; Tveit, Kjell M; Hjermstad, Marianne J; Johansson, Hemming et al.

Part of European Journal of Cancer, p. 813-819, 2012

• DOI for Health-related quality of life (HRQoL) after multimodal treatment for primarily non-resectable rectal cancer: Long-term results from a phase III study

Dummy Run in the Phase III LAP07 Pancreatic Cancer Trial: First Evaluation of Quality of Radiation Therapy Planning

Racadot, S.; Hammel, P.; Chibaudel, B.; Goldstein, D. et al.

Part of International Journal of Radiation Oncology, Biology, Physics, 2012

Radiation response in colorectal cancer cells

Sahlberg, Sara Haggblad; Gustafsson, Ann-Sofie; Glimelius, Bengt; Stenerlöw, Bo

Part of International Journal of Molecular Medicine, 2012

Allele-specific copy number analysis of tumor samples with aneuploidy and tumor heterogeneity

Rasmussen, Markus; Sundström, Magnus; Kultima, Hanna Göransson; Botling, Johan et al.

Part of Genome Biology, 2011

• DOI for Allele-specific copy number analysis of tumor samples with aneuploidy and tumor heterogeneity
• Download full text (pdf) of Allele-specific copy number analysis of tumor samples with aneuploidy and tumor heterogeneity

Survival endpoints in colorectal cancer and the effect of second primary other cancer on disease free survival

Birgisson, Helgi; Wallin, Ulrik; Holmberg, Lars; Glimelius, Bengt

Part of BMC Cancer, p. 438, 2011

• DOI for Survival endpoints in colorectal cancer and the effect of second primary other cancer on disease free survival
• Download full text (pdf) of Survival endpoints in colorectal cancer and the effect of second primary other cancer on disease free survival

Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer

Wallin, Ulrik; Glimelius, Bengt; Jirström, K.; Darmanis, Spyros et al.

Part of British Journal of Cancer, p. 1619-1627, 2011

• DOI for Growth differentiation factor 15: a prognostic marker for recurrence in colorectal cancer

GWAS of Follicular Lymphoma Reveals Allelic Heterogeneity at 6p21.32 and Suggests Shared Genetic Susceptibility with Diffuse Large B-cell Lymphoma

Smedby, Karin E.; Foo, Jia Nee; Skibola, Christine F.; Darabi, Hatef et al.

Part of PLoS Genetics, 2011

• DOI for GWAS of Follicular Lymphoma Reveals Allelic Heterogeneity at 6p21.32 and Suggests Shared Genetic Susceptibility with Diffuse Large B-cell Lymphoma

The Effects of Short-Course Preoperative Irradiation on Local Recurrence Rate and Survival in Rectal Cancer: A Population-Based Nationwide Study

Tiefenthal, Marit; Nilsson, Per J.; Johansson, Robert; Glimelius, Bengt et al.

Part of Diseases of the Colon & Rectum, p. 672-680, 2011

• DOI for The Effects of Short-Course Preoperative Irradiation on Local Recurrence Rate and Survival in Rectal Cancer: A Population-Based Nationwide Study

Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer

Glimelius, Bengt; Garmo, Hans; Berglund, Åke; Fredriksson, L. A. et al.

Part of The Pharmacogenomics Journal, p. 61-71, 2011

• DOI for Prediction of irinotecan and 5-fluorouracil toxicity and response in patients with advanced colorectal cancer

Socioeconomic inequalities in the use of radiotherapy for rectal cancer: A nationwide study

Olsson, L. I.; Granström, F.; Glimelius, Bengt

Part of European Journal of Cancer, p. 347-353, 2011

• DOI for Socioeconomic inequalities in the use of radiotherapy for rectal cancer: A nationwide study

Communication analysis in oncology care: Performance of a combination of a content analysis system and a global scale

Fagerlind, Hanna; Bergström, Ida; Kettis, Åsa; Velikova, Galina et al.

Part of Psycho-Oncology, p. 992-1000, 2011

• DOI for Communication analysis in oncology care: Performance of a combination of a content analysis system and a global scale

Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial

van Gijn, Willem; Marijnen, Carrie A. M.; Nagtegaal, Iris D.; Kranenbarg, Elma Meershoek-Klein et al.

Part of The Lancet Oncology, p. 575-582, 2011

• DOI for Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial

Comparing two versions of the Schedule for Evaluation of Individual Quality of Life in patients with advanced cancer

Wettergren, Lena; Kettis, Åsa; Glimelius, Bengt; Ring, Lena

Part of Acta Oncologica, p. 648-652, 2011

• DOI for Comparing two versions of the Schedule for Evaluation of Individual Quality of Life in patients with advanced cancer

Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancer

Frederiksen, C.; Qvortrup, C.; Christensen, I. J.; Glimelius, Bengt et al.

Part of Annals of Oncology, p. 369-375, 2011

• DOI for Plasma TIMP-1 levels and treatment outcome in patients treated with XELOX for metastatic colorectal cancer

Differences according to educational level in the management and survival of colorectal cancer in Sweden

Cavalli-Björkman, Nina; Lambe, Mats; Eaker, Sonja; Sandin, Fredrik et al.

Part of European Journal of Cancer, p. 1398-1406, 2011

• DOI for Differences according to educational level in the management and survival of colorectal cancer in Sweden

Tumour budding correlates with local recurrence of rectal cancer

Syk, E.; Lenander, C.; Nilsson, P. J.; Rubio, C. A. et al.

Part of Colorectal Disease, p. 255-262, 2011

• DOI for Tumour budding correlates with local recurrence of rectal cancer

Mesorectal Fascia Instead of Circumferential Resection Margin in Preoperative Staging of Rectal Cancer

Glimelius, Bengt; Beets-Tan, Regina; Blomqvist, Lennart; Brown, Gina et al.

Part of Journal of Clinical Oncology, p. 2142-2143, 2011

• DOI for Mesorectal Fascia Instead of Circumferential Resection Margin in Preoperative Staging of Rectal Cancer

SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal Carcinomas

Magnusson, Kristina; de Wit, Meike; Brennan, Donal J.; Johnson, Louis B. et al.

Part of American Journal of Surgical Pathology, p. 937-948, 2011

• DOI for SATB2 in Combination With Cytokeratin 20 Identifies Over 95% of all Colorectal Carcinomas

EGFR, HER2 and HER3 expression in primary colorectal carcinomas and corresponding metastases: Implications for targeted radionuclide therapy

Wei, Q.; Shui, Y.; Zheng, S.; Wester, Kenneth et al.

Part of Oncology Reports, p. 3-11, 2011

• DOI for EGFR, HER2 and HER3 expression in primary colorectal carcinomas and corresponding metastases: Implications for targeted radionuclide therapy

Particle therapy: a next logical step in the improvement of radiotherapy

Nyström, Håkan; Blomqvist, Erik; Høyer, Morten; Montelius, Anders et al.

Part of Acta Oncologica, p. 741-744, 2011

• DOI for Particle therapy: a next logical step in the improvement of radiotherapy

And they lived happily ever after… The marriage of Nordic Association for Clinical Physics and Acta Oncologica

Muren, Ludvig P; Glimelius, Bengt

Part of Acta Oncologica, p. 835-837, 2011

• DOI for And they lived happily ever after… The marriage of Nordic Association for Clinical Physics and Acta Oncologica

Novel activity of acriflavine against colorectal cancer tumor cells

Hassan, Saadia; Laryea, Daniel; Mahteme, Haile; Felth, Jenny et al.

Part of Cancer Science, p. 2206-2213, 2011

• DOI for Novel activity of acriflavine against colorectal cancer tumor cells

Late patient-reported toxicity after preoperative radiotherapy or chemoradiotherapy in nonresectable rectal cancer: Results from a randomized phase III study

Braendengen, Morten; Tveit, Kjell Magne; Bruheim, Kjersti; Cvancarova, Milada et al.

Part of International Journal of Radiation Oncology, Biology, Physics, p. 1017-1024, 2011

• DOI for Late patient-reported toxicity after preoperative radiotherapy or chemoradiotherapy in nonresectable rectal cancer: Results from a randomized phase III study

Delineation of gross tumor volume (GTV) for radiation treatment planning of locally advanced rectal cancer using information from MRI or FDG-PET/CT: a prospective study

Brændengen, Morten; Hansson, Karl; Radu, Calin; Siegbahn, Albert et al.

Part of International Journal of Radiation Oncology, Biology, Physics, 2011

• DOI for Delineation of gross tumor volume (GTV) for radiation treatment planning of locally advanced rectal cancer using information from MRI or FDG-PET/CT: a prospective study

Lack of association between the MDM2 promoter polymorphism SNP309 and clinical outcome in chronic lymphocytic leukemia

Kaderi, Mohd Arifin; Mansouri, Mahmoud; Zainuddin, Norafiza; Cahill, Nicola et al.

Part of Leukemia Research, p. 335-339, 2010

• DOI for Lack of association between the MDM2 promoter polymorphism SNP309 and clinical outcome in chronic lymphocytic leukemia
• Download full text (pdf) of Lack of association between the MDM2 promoter polymorphism SNP309 and clinical outcome in chronic lymphocytic leukemia

KRAS analysis in colorectal carcinoma: analytical aspects of Pyrosequencing and allele-specific PCR in clinical practice

Sundström, Magnus; Edlund, Karolina; Lindell, Monica; Glimelius, Bengt et al.

Part of BMC Cancer, p. 660, 2010

• DOI for KRAS analysis in colorectal carcinoma: analytical aspects of Pyrosequencing and allele-specific PCR in clinical practice

Magnetic resonance imaging (MRI) in rectal cancer: a comprehensive review

Torkzad, Michael R.; Påhlman, Lars; Glimelius, Bengt

Part of Insights into Imaging, p. 245-267, 2010

• DOI for Magnetic resonance imaging (MRI) in rectal cancer: a comprehensive review

A randomized study comparing short-time infusion of oxaliplatin in combination with capecitabine XELOX(30) and chronomodulated XELOX(30) as first-line therapy in patients with advanced colorectal cancer

Qvortrup, Camilla; Jensen, B. V.; Fokstuen, T.; Nielsen, S. E. et al.

Part of Annals of Oncology, p. 87-91, 2010

• DOI for A randomized study comparing short-time infusion of oxaliplatin in combination with capecitabine XELOX(30) and chronomodulated XELOX(30) as first-line therapy in patients with advanced colorectal cancer

Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009

Van Cutsem, E.; Dicato, M.; Arber, N.; Berlin, J. et al.

Part of Annals of Oncology, p. 1-10, 2010

• DOI for Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009

Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer

Pettersson, D.; Cedermark, B.; Holm, T.; Radu, Calin et al.

Part of British Journal of Surgery, p. 580-587, 2010

• DOI for Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer

Multicentre phase I-II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable pancreatic and biliary tract cancer: The CORGI-U study

Gunnlaugsson, Adalsteinn; Anderson, Harald; Lind, Pehr; Glimelius, Bengt et al.

Part of Radiotherapy and Oncology, p. 292-297, 2010

• DOI for Multicentre phase I-II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable pancreatic and biliary tract cancer: The CORGI-U study

Factors influencing local failure in rectal cancer: analysis of 2315 patients from a population-based series

Syk, Erik; Glimelius, Bengt; Nilsson, P. J.

Part of Diseases of the Colon & Rectum, p. 744-752, 2010

• DOI for Factors influencing local failure in rectal cancer: analysis of 2315 patients from a population-based series

Any progress in pancreatic cancer? Well, but progress for Acta Oncologica

Glimelius, Bengt

Part of Acta Oncologica, p. 404-406, 2010

• DOI for Any progress in pancreatic cancer? Well, but progress for Acta Oncologica

Adjuvant chemotherapy in rectal cancer: an issue or a nonissue?

Glimelius, Bengt

Part of Annals of Oncology, p. 1739-1741, 2010

• DOI for Adjuvant chemotherapy in rectal cancer: an issue or a nonissue?

An explorative study on the clinical utility of baseline and serial serum tumour marker measurements in advanced upper gastrointestinal cancer

Byström, P.; Berglund, Åke; Nygren, Peter; Wernroth, Mona-Lisa et al.

Part of Oncology Reports, p. 1645-1652, 2010

• DOI for An explorative study on the clinical utility of baseline and serial serum tumour marker measurements in advanced upper gastrointestinal cancer

Preoperative plasma TIMP-1 is an independent prognostic indicator in patients with primary colorectal cancer: a prospective validation study

Birgisson, Helgi; Nielsen, Hans J.; Christensen, Ib Jarle; Glimelius, Bengt et al.

Part of European Journal of Cancer, p. 3323-3331, 2010

• DOI for Preoperative plasma TIMP-1 is an independent prognostic indicator in patients with primary colorectal cancer: a prospective validation study

Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial

Gubanski, Michael; Johnsson, Anders; Fernebro, Eva; Kadar, Lianna et al.

Part of Gastric Cancer, p. 155-161, 2010

• DOI for Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial

Does socioeconomic status influence the prospect of cure from colon cancer - A population-based study in Sweden 1965-2000

Eloranta, S.; Lambert, P. C.; Cavalli-Björkman, Nina; Andersson, T. M-L et al.

Part of European Journal of Cancer, p. 2965-2972, 2010

• DOI for Does socioeconomic status influence the prospect of cure from colon cancer - A population-based study in Sweden 1965-2000

Factors associated with psychological distress and grief resolution in surviving spouses of patients with advanced gastrointestinal cancer

Winterling, Jeanette; Wasteson, Elisabet; Arving, Cecilia; Johansson, Birgitta et al.

Part of Supportive Care in Cancer, p. 1377-1384, 2010

• DOI for Factors associated with psychological distress and grief resolution in surviving spouses of patients with advanced gastrointestinal cancer

A window of opportunity phase II study of enzastaurin in chemonaive patients with asymptomatic metastatic colorectal cancer

Glimelius, Bengt; Lahn, M.; Gawande, S.; Cleverly, A. et al.

Part of Annals of Oncology, p. 1020-1026, 2010

• DOI for A window of opportunity phase II study of enzastaurin in chemonaive patients with asymptomatic metastatic colorectal cancer

Long-term follow-up of chemonaive patients with asymptomatic metastatic colorectal cancer treated with enzastaurin in a window of opportunity phase II study

Glimelius, Bengt; Spindler, K. L.; Frödin, J-E.; Berglund, Åke et al.

Part of Annals of Oncology, p. 1127-1128, 2010

• DOI for Long-term follow-up of chemonaive patients with asymptomatic metastatic colorectal cancer treated with enzastaurin in a window of opportunity phase II study

An explorative randomised phase II study of sequential chemotherapy in advanced upper gastrointestinal cancer

Berglund, Åke; Byström, Per; Johansson, Birgitta; Nygren, Peter et al.

Part of Medical Oncology, p. 65-72, 2010

• DOI for An explorative randomised phase II study of sequential chemotherapy in advanced upper gastrointestinal cancer

Effects of an EGFR-binding affibody molecule on intracellular signaling pathways

Nordberg, Erika; Ekerljung, Lina; Häggblad Sahlberg, Sara; Carlsson, Jörgen et al.

Part of International Journal of Oncology, p. 967-972, 2010

• DOI for Effects of an EGFR-binding affibody molecule on intracellular signaling pathways

High Plasma TIMP-1 and Serum CEA Levels during Combination Chemotherapy for Metastatic Colorectal Cancer Are Significantly Associated with Poor Outcome

Aldulaymi, Bahir; Byström, Per; Berglund, Åke; Christensen, Ib J. et al.

Part of Oncology, p. 144-149, 2010

• DOI for High Plasma TIMP-1 and Serum CEA Levels during Combination Chemotherapy for Metastatic Colorectal Cancer Are Significantly Associated with Poor Outcome

Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32

Conde, Lucia; Halperin, Eran; Akers, Nicholas K.; Brown, Kevin M. et al.

Part of Nature Genetics, p. 661-664, 2010

• DOI for Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32

In memoriam - Lars-Gunnar Larsson 1919-2009

Glimelius, Bengt; Lindstam, Leif

Part of Acta Oncologica, p. 132-133, 2010

• DOI for In memoriam - Lars-Gunnar Larsson 1919-2009

HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma

Hjalgrim, Henrik; Rostgaard, Klaus; Johnson, Paul C. D.; Lake, Annette et al.

Part of Proceedings of the National Academy of Sciences of the United States of America, p. 6400-6405, 2010

• DOI for HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma

Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Glimelius, Bengt; Påhlman, Lars; Cervantes, A.

Part of Annals of Oncology, 2010

• DOI for Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Can DNA sampling from the rectal mucosa be a novel tool for the detection of colorectal cancer?

Wallin, Ulrik; Gunnarsson, Ulf; Glimelius, Bengt; Loktionov, Alexandre et al.

Part of International Journal of Colorectal Disease, p. 1071-1078, 2010

• DOI for Can DNA sampling from the rectal mucosa be a novel tool for the detection of colorectal cancer?

Rectal cancer radiotherapy: Towards European consensus

Valentini, Vincenzo; Glimelius, Bengt

Part of Acta Oncologica, p. 1206-1216, 2010

• DOI for Rectal cancer radiotherapy: Towards European consensus

Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy

Bernhard, J.; Dietrich, D.; Glimelius, Bengt; Hess, V. et al.

Part of British Journal of Cancer, p. 1318-1324, 2010

• DOI for Estimating prognosis and palliation based on tumour marker CA 19-9 and quality of life indicators in patients with advanced pancreatic cancer receiving chemotherapy

Evidence-based medicine: the time has come to set standards for staging

Quirke, Phil; Cuvelier, Claude; Ensari, Arzu; Glimelius, Bengt et al.

Part of Journal of Pathology, p. 357-360, 2010

• DOI for Evidence-based medicine: the time has come to set standards for staging

A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)

Enciso-Mora, Victor; Broderick, Peter; Ma, Yussanne; Jarrett, Ruth F. et al.

Part of Nature Genetics, p. 1126-1130, 2010

• DOI for A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)

Immunoglobulin subclass levels in patients with non-Hodgkin lymphoma

Biggar, Robert J.; Christiansen, Michael; Rostgaard, Klaus; Smedby, Karin Ekström et al.

Part of International Journal of Cancer, p. 2616-20, 2009

• DOI for Immunoglobulin subclass levels in patients with non-Hodgkin lymphoma

Expectations for the recovery period after cancer treatment – a qualitative study

Winterling, Jeanette; Sidenvall, Birgitta; Glimelius, Bengt; Nordin, Karin

Part of European Journal of Cancer Care, p. 585-593, 2009

• DOI for Expectations for the recovery period after cancer treatment – a qualitative study

Multicentre phase II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable colorectal cancer: The CORGI-L study

Gunnlaugsson, Adalsteinn; Anderson, Harald; Fernebro, Eva; Kjellén, Elisabeth et al.

Part of European Journal of Cancer, p. 807-813, 2009

• DOI for Multicentre phase II trial of capecitabine and oxaliplatin in combination with radiotherapy for unresectable colorectal cancer: The CORGI-L study

Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer

Byström, Per; Berglund, A.; Garske, Ulrike Garske; Jacobsson, H. et al.

Part of Annals of Oncology, p. 1057-1061, 2009

• DOI for Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer

Reply to FDG-PET: for early prediction of response to the first-line chemotherapy in metastatic colorectal cancer?

Byström, P.; Glimelius, Bengt

Part of Annals of Oncology, p. 1150-1150, 2009

• DOI for Reply to FDG-PET: for early prediction of response to the first-line chemotherapy in metastatic colorectal cancer?

Rectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up

Glimelius, Bengt; Oliveira, J.

Part of Annals of Oncology, p. 54-6, 2009

• DOI for Rectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up

Postoperative morbidity and mortality in relation to leukocyte counts and time to surgery after short-course preoperative radiotherapy for rectal cancer

Fokstuen, Tone; Holm, Torbjörn; Glimelius, Bengt

Part of Radiotherapy and Oncology, p. 293-297, 2009

• DOI for Postoperative morbidity and mortality in relation to leukocyte counts and time to surgery after short-course preoperative radiotherapy for rectal cancer

Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients

Sorbye, Halfdan; Pfeiffer, Per; Cavalli-Björkman, Nina; Qvortrup, Camilla et al.

Part of Cancer, p. 4679-87, 2009

• DOI for Clinical trial enrollment, patient characteristics, and survival differences in prospectively registered metastatic colorectal cancer patients

The correlation between a family history of colorectal cancer and survival of patients with colorectal cancer

Birgisson, Helgi; Ghanipour, Arezo; Smedh, Kennet; Påhlman, Lars et al.

Part of Familial Cancer, p. 555-561, 2009

• DOI for The correlation between a family history of colorectal cancer and survival of patients with colorectal cancer

The prognostic significance of tryptophanyl-tRNA synthetase in colorectal cancer

Ghanipour, Arezo; Jirström, Karin; Pontén, Fredrik; Glimelius, Bengt et al.

Part of Cancer Epidemiology, Biomarkers and Prevention, p. 2949-2956, 2009

• DOI for The prognostic significance of tryptophanyl-tRNA synthetase in colorectal cancer

High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer

Gaber, A.; Johansson, M.; Stenman, U-H.; Hotakainen, K. et al.

Part of British Journal of Cancer, p. 1540-1548, 2009

• DOI for High expression of tumour-associated trypsin inhibitor correlates with liver metastasis and poor prognosis in colorectal cancer

Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma

Worrillow, Lisa; Smith, Alex; Scott, Kathryn; Andersson, Michael et al.

Part of Journal of Medical Genetics, p. 142-146, 2008

• DOI for Polymorphic MLH1 and risk of cancer after methylating chemotherapy for Hodgkin lymphoma

Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.

Nordlinger, Bernard; Sorbye, Halfdan; Glimelius, Bengt; Poston, Graeme J et al.

Part of The Lancet, p. 1007-1016, 2008

• DOI for Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.

A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer

Glimelius, Bengt; Sørbye, H; Balteskard, L; Byström, P et al.

Part of Annals of Oncology, p. 909-914, 2008

• DOI for A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer

Patient-physician communication during oncology consultations

Fagerlind, Hanna; Kettis, Åsa; Bergström, Ida; Nilsson, Magdalena et al.

Part of Psycho-Oncology, p. 975-985, 2008

• DOI for Patient-physician communication during oncology consultations

Borrelia infection and risk of non-Hodgkin lymphoma

Schöllkopf, Claudia; Melbye, Mads; Munksgaard, Lars; Smedby, Karin Ekström et al.

Part of Blood, p. 5524-5529, 2008

• DOI for Borrelia infection and risk of non-Hodgkin lymphoma

In vivo and in vitro uptake of In-111, delivered with the affibody molecule(Z(EGFR:955))(2), in EGFR expressing tumour cells

Nordberg, Erika; Orlova, Anna; Friedman, M.; Tolmachev, Vladimir et al.

Part of Oncology Reports, p. 853-857, 2008

Reference dosimetry in a scanned pulsed proton beam using ionisation chambers and a Faraday cup

Lorin, Stefan; Grusell, Erik; Tilly, Nina; Medin, Joakim et al.

Part of Physics in Medicine and Biology, p. 3519-3529, 2008

• DOI for Reference dosimetry in a scanned pulsed proton beam using ionisation chambers and a Faraday cup

The 'good', the 'bad', and the 'ugly' rectal cancers.

Blomqvist, Lennart; Glimelius, Bengt

Part of Acta Oncol, p. 5-8, 2008

Systemic exposure of the parent drug oxaliplatin during hyperthermic intraperitoneal perfusion

Mahteme, Haile; Wallin, I; Glimelius, Bengt; Påhlman, Lars et al.

Part of European Journal of Clinical Pharmacology, p. 907-911, 2008

• DOI for Systemic exposure of the parent drug oxaliplatin during hyperthermic intraperitoneal perfusion

Hepatitis C infection and risk of malignant lymphoma

Schöllkopf, Claudia; Smedby, Karin Ekström; Hjalgrim, Henrik; Rostgaard, Klaus et al.

Part of International Journal of Cancer, p. 1885-1890, 2008

• DOI for Hepatitis C infection and risk of malignant lymphoma

Local recurrence in rectal cancer: anatomic localization and effect on radiation target

Syk, Erik; Torkzad, Michael R.; Blomqvist, Lennart; Nilsson, Per J. et al.

Part of International Journal of Radiation Oncology, Biology, Physics, p. 658-64, 2008

• DOI for Local recurrence in rectal cancer: anatomic localization and effect on radiation target

Short-course preoperative radiotherapy with delayed surgery in rectal cancer: a retrospective study

Radu, Calin; Berglund, Åke; Påhlman, Lars; Glimelius, Bengt

Part of Radiotherapy and Oncology, p. 343-9, 2008

• DOI for Short-course preoperative radiotherapy with delayed surgery in rectal cancer: a retrospective study

Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer

Braendengen, Morten; Tveit, Kjell M.; Berglund, Åke; Birkemeyer, Elke et al.

Part of Journal of Clinical Oncology, p. 3687-3694, 2008

• DOI for Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer

Four weeks of daily assessments of anxiety, depression and activity compared to a point assessment with the Hospital Anxiety and Depression Scale

Arving, Cecilia; Glimelius, Bengt; Brandberg, Yvonne

Part of Quality of Life Research, p. 95-104, 2008

• DOI for Four weeks of daily assessments of anxiety, depression and activity compared to a point assessment with the Hospital Anxiety and Depression Scale

Health-related quality of life and distress in cancer patients: results from a large randomised study

Johansson, Birgitta; Brandberg, Y.; Hellbom, M.; Persson, Christina et al.

Part of British Journal of Cancer, p. 1975-1983, 2008

• DOI for Health-related quality of life and distress in cancer patients: results from a large randomised study

Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001

Bernhard, Jürg; Dietrich, Daniel; Scheithauer, Werner; Gerber, Daniela et al.

Part of Journal of Clinical Oncology, p. 3695-3701, 2008

• DOI for Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001

Serum YKL-40 and interleukin 6 levels in Hodgkin lymphoma

Biggar, Robert J.; Johansen, Julia S.; Smedby, Karin Ekström; Rostgaard, Klaus et al.

Part of Clinical Cancer Research, p. 6974-8, 2008

• DOI for Serum YKL-40 and interleukin 6 levels in Hodgkin lymphoma

CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial

Hess, Viviane; Glimelius, Bengt; Grawe, Philipp; Dietrich, Daniel et al.

Part of The Lancet Oncology, p. 132-8, 2008

• DOI for CA 19-9 tumour-marker response to chemotherapy in patients with advanced pancreatic cancer enrolled in a randomised controlled trial

The dream of a philologist

Glimelius, Bengt

Part of Acta Oncologica, p. 991-993, 2008

• DOI for The dream of a philologist

Heterogeneous activity of cytotoxic drugs in patient samples of peritoneal carcinomatosis

Mahteme, Haile; von Heideman, Anne; Grundmark, Birgitta; Tholander, B. et al.

Part of European Journal of Surgical Oncology, p. 547-552, 2008

• DOI for Heterogeneous activity of cytotoxic drugs in patient samples of peritoneal carcinomatosis

The importance of expectations on the recovery period after cancer treatment

Winterling, Jeanette; Glimelius, Bengt; Nordin, Karin

Part of Psycho-Oncology, p. 190-198, 2008

• DOI for The importance of expectations on the recovery period after cancer treatment

Is it deleterious to delay the start of adjuvant chemotherapy in colon cancer stage III?

Berglund, Åke; Cedermark, B; Glimelius, Bengt

Part of Annals of Oncology, p. 400-402, 2008

• DOI for Is it deleterious to delay the start of adjuvant chemotherapy in colon cancer stage III?

Individual psychosocial support for breast cancer patients: A randomized study of nurse vs. psychologist interventions and standard care

Arving, Cecilia; Sjödén, Per-Olow; Bergh, Jonas; Hellbom, Maria et al.

Part of Cancer Nursing, 2007

• DOI for Individual psychosocial support for breast cancer patients: A randomized study of nurse vs. psychologist interventions and standard care

Adjuvant behandling av ventrikelcancer prövas i Sverige

Glimelius, Bengt; Lind, Pehr; Lundell, Lars

Part of Läkartidningen, p. 3214-3215, 2007

Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group

Herrmann, Richard; Bodoky, György; Ruhstaller, Thomas; Glimelius, Bengt et al.

Part of Journal of Clinical Oncology, p. 2212-2217, 2007

• DOI for Gemcitabine plus capecitabine compared with gemcitabine alone in advanced pancreatic cancer: a randomized, multicenter, phase III trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group

A beam source model for scanned proton beams

Kimstrand, Peter; Traneus, Erik; Ahnesjö, Anders; Grusell, Erik et al.

Part of Physics in Medicine and Biology, p. 3151-3168, 2007

• DOI for A beam source model for scanned proton beams

The TME trial after a median follow-up of 6 years: Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma

Peeters, Koen C. M.J.; Marijnen, Corrie A. M.; Nagtegaal, Iris D.; Kranenbarg, Elma Klein et al.

Part of Annals of Surgery, p. 693-701, 2007

• DOI for The TME trial after a median follow-up of 6 years: Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma

Cigarette smoking and risk of Hodgkin lymphoma: a population-based case-control study

Hjalgrim, Henrik; Ekström-Smedby, Karin; Rostgaard, Klaus; Amini, Rose-Marie et al.

Part of Cancer Epidemiology, Biomarkers and Prevention, p. 1561-1566, 2007

• DOI for Cigarette smoking and risk of Hodgkin lymphoma: a population-based case-control study

Late adverse effects of radiation therapy for rectal cancer: a systematic overview

Birgisson, Helgi; Påhlman, Lars; Gunnarsson, Ulf; Glimelius, Bengt

Part of Acta Oncologica, p. 504-516, 2007

• DOI for Late adverse effects of radiation therapy for rectal cancer: a systematic overview

Temporal trends in the proportion cured for cancer of the colon and rectum: a population-based study using data from the Finnish Cancer Registry

Lambert, Paul C.; Dickman, Paul W.; Österlund, Pia; Andersson, Therese et al.

Part of International Journal of Cancer, p. 2052-2059, 2007

• DOI for Temporal trends in the proportion cured for cancer of the colon and rectum: a population-based study using data from the Finnish Cancer Registry

Acta Oncologica--achievements during 2006 and a look at the future

Glimelius, Bengt

Part of Acta Oncologica, p. 5-7, 2007

• DOI for Acta Oncologica--achievements during 2006 and a look at the future

Evaluation of beta globin mRNA as an early marker of haemoglobin response to epoetin treatment

Birgegård, Gunnar; Dahl, Fredrik; Glimelius, Bengt; Landegren, Ulf

Part of Medical Oncology, p. 318-322, 2007

• DOI for Evaluation of beta globin mRNA as an early marker of haemoglobin response to epoetin treatment

In reply to Dr Courdi - Biologically equivalent doses (IN 2 gY/FR) TO 5 x 5 Gy

Glimelius, Bengt; Isacsson, Ulf

Part of Acta Oncologica, p. 396-396, 2007

• DOI for In reply to Dr Courdi - Biologically equivalent doses (IN 2 gY/FR) TO 5 x 5 Gy

Patient characteristics and stratification in medical treatment studies for metastatic colorectal cancer: a proposal for standardization of patient characteristic reporting and stratification

Sorbye, H.; Köhne, C-H; Sargent, D. J.; Glimelius, Bengt

Part of Annals of Oncology, p. 1666-1672, 2007

• DOI for Patient characteristics and stratification in medical treatment studies for metastatic colorectal cancer: a proposal for standardization of patient characteristic reporting and stratification

Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule

Nordberg, Erika; Friedman, Mikaela; Göstring, Lovisa; Adams, Gregory et al.

Part of Nuclear Medicine and Biology, p. 609-618, 2007

• DOI for Cellular studies of binding, internalization and retention of a radiolabeled EGFR-binding affibody molecule

Development and verification of the pulsed scanned proton beam at the The Swedberg Laboratory in Uppsala

Tilly, Nina; Grusell, Erik; Kimstrand, Peter; Lorin, Stefan et al.

Part of Physics in Medicine and Biology, p. 2741-2754, 2007

• DOI for Development and verification of the pulsed scanned proton beam at the The Swedberg Laboratory in Uppsala

Secondary treatment and predictive factors for second-line chemotherapy after first-line oxaliplatin-based therapy in metastatic colorectal cancer

Sørbye, Halfdan; Berglund, Åke; Tveit, Kjell Magne; Ogreid, Dagfinn et al.

Part of Acta Oncologica, p. 982-988, 2007

• DOI for Secondary treatment and predictive factors for second-line chemotherapy after first-line oxaliplatin-based therapy in metastatic colorectal cancer

TIMP-1 is significantly associated with objective response and survival in metastatic colorectal cancer patients receiving combination of irinotecan, 5-fluorouracil, and folinic acid

Sørensen, Nanna M; Byström, Per; Christensen, Ib J; Berglund, Åke et al.

Part of Clinical Cancer Research, p. 4117-4122, 2007

• DOI for TIMP-1 is significantly associated with objective response and survival in metastatic colorectal cancer patients receiving combination of irinotecan, 5-fluorouracil, and folinic acid

Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma

Hjalgrim, Henrik; Smedby, Karin Ekström; Rostgaard, Klaus; Molin, Daniel et al.

Part of Cancer Research, p. 2382-2388, 2007

• DOI for Infectious mononucleosis, childhood social environment, and risk of Hodgkin lymphoma

The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006

Verslype, C.; Van Cutsem, E.; Dicato, M.; Cascinu, S. et al.

Part of Annals of Oncology, 2007

• DOI for The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006

Childhood social environment and risk of non-Hodgkin lymphoma in adults

Ekström Smedby, Karin; Hjalgrim, Henrik; Chang, Ellen T.; Rostgaard, Klaus et al.

Part of Cancer Research, p. 11074-11082, 2007

• DOI for Childhood social environment and risk of non-Hodgkin lymphoma in adults

Human papillomavirus (HPV), DNA aberrations and cell cycle progression in anal squamous cell carcinoma patients

Laytragoon-Lewin, Nongnit; Nilsson, Per J.; Castro, Juan; Gharizadeh, Baback et al.

Part of Anticancer Research, p. 4473-4479, 2007

Proton beam therapy - do we need the randomised trials and can we do them?

Glimelius, Bengt; Montelius, Anders

Part of Radiotherapy and Oncology, p. 105-109, 2007

• DOI for Proton beam therapy - do we need the randomised trials and can we do them?

Atopy and risk of non-Hodgkin lymphoma

Melbye, Mads; Smedby, Karin Ekström; Lehtinen, Tuula; Rostgaard, Klaus et al.

Part of Journal of the National Cancer Institute, p. 158-166, 2007

• DOI for Atopy and risk of non-Hodgkin lymphoma

Loco-regional Recurrence from Colon Cancer: A Population-based Study

Sjövall, Annika; Granath, Fredrik; Cedermark, Björn; Glimelius, Bengt et al.

Part of Annals of Surgical Oncology, p. 432-440, 2007

• DOI for Loco-regional Recurrence from Colon Cancer: A Population-based Study

MRI after preoperative radiotherapy for rectal cancer; correlation with histopathology and the role of volumetry.

Torkzad, Michael R.; Lindholm, Johan; Martling, Anna; Cedermark, Björn et al.

Part of European Radiology, p. 1566-1573, 2007

• DOI for MRI after preoperative radiotherapy for rectal cancer; correlation with histopathology and the role of volumetry.

Colon cancer management and outcome in relation to individual hospitals in a defined population

Sjövall, A.; Holm, T.; Singnomklao, T.; Granath, F. et al.

Part of British Journal of Surgery, p. 491-499, 2007

• DOI for Colon cancer management and outcome in relation to individual hospitals in a defined population

Patients'and doctors' views of using the schedule for individual quality of life in clinical practice.

Kettis, Åsa; Ring, Lena; Widmark, Elisabeth; Bendtsen, Preben et al.

Part of JOURNAL OF SUPPORTIVE ONCOLOGY, p. 281-287, 2007

Incidence of non-Hodgkin's lymphoma in Sweden, Denmark, and Finland from 1960 through 2003: an epidemic that was

Sandin, Sven; Hjalgrim, Henrik; Glimelius, Bengt; Rostgaard, Klaus et al.

Part of Cancer Epidemiology, Biomarkers and Prevention, p. 1295-1300, 2006

• DOI for Incidence of non-Hodgkin's lymphoma in Sweden, Denmark, and Finland from 1960 through 2003: an epidemic that was

Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype

Smedby, Karin Ekström; Hjalgrim, Henrik; Askling, Johan; Chang, Ellen T. et al.

Part of Journal of the National Cancer Institute, p. 51-60, 2006

• DOI for Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype

Feasibility and validity of a computer administered version of SEIQoL-DW

Ring, Lena; Kettis Lindblad, Åsa; Bendtsen, P; Viklund, E et al.

Part of Quality of Life Research, p. 1173-1177, 2006

• DOI for Feasibility and validity of a computer administered version of SEIQoL-DW

U-2940, a human B-cell line derived from a diffuse large cell lymphoma sequential to Hodgkin lymphoma.

Sambade, Clara; Berglund, Mattias; Lagercrantz, Svetlana; Sällström, Jan et al.

Part of Int J Cancer, p. 555-63, 2006

Impact of fish oil and melatonin on cachexia in patients with advanced gastrointestinal cancer: a randomized pilot study.

Persson, Christina; Glimelius, Bengt; Rönnelid, Johan; Nygren, Peter

Part of Nutrition, p. 170-8, 2005

Family history of hematopoietic malignancy and risk of lymphoma

Chang, Ellen T.; Ekström Smedby, Karin; Hjalgrim, Henrik; Porwit-MacDonald, Anna et al.

Part of Journal of the National Cancer Institute, p. 1466-1474, 2005

• DOI for Family history of hematopoietic malignancy and risk of lymphoma

Medication use and risk of non-Hodgkin's lymphoma

Chang, Ellen T.; Smedby, Karin Ekström; Hjalgrim, Henrik; Schöllkopf, Claudia et al.

Part of American Journal of Epidemiology, p. 965-974, 2005

• DOI for Medication use and risk of non-Hodgkin's lymphoma

The influence of RBE variations in a clinical proton treatment plan for a hypopharynx cancer

Tilly, Nina; Johansson, Jonas; Isacsson, Ulf; Medin, Joakim et al.

Part of Physics in Medicine and Biology, p. 2765-2777, 2005

• DOI for The influence of RBE variations in a clinical proton treatment plan for a hypopharynx cancer

Ultraviolet radiation exposure and risk of malignant lymphomas

Smedby, Karin Ekström; Hjalgrim, Henrik; Melbye, Mads; Torrång, Anna et al.

Part of Journal of the National Cancer Institute, p. 199-209, 2005

• DOI for Ultraviolet radiation exposure and risk of malignant lymphomas

Body mass index and risk of malignant lymphoma in Scandinavian men and women

Chang, Ellen T.; Hjalgrim, Henrik; Ekström Smedby, Karin; Åkerman, Måns et al.

Part of Journal of the National Cancer Institute, p. 210-218, 2005

• DOI for Body mass index and risk of malignant lymphoma in Scandinavian men and women

Cigarette smoking and risk of non-Hodgkin's lymphoma: a population-based case-control study

Schöllkopf, Claudia; Smedby, Karin Ekström; Hjalgrim, Henrik; Rostgaard, Klaus et al.

Part of Cancer Epidemiology, Biomarkers and Prevention, p. 1791-1796, 2005

• DOI for Cigarette smoking and risk of non-Hodgkin's lymphoma: a population-based case-control study

Cellular uptake of radioiodine delivered by trastuzumab can be modified by the addition of epidermal growth factor.

Nordberg, Erika; Steffen, Ann-Charlott; Persson, Mikael; Sundberg, Åsa L. et al.

Part of European Journal of Nuclear Medicine and Molecular Imaging, p. 771-7, 2005

• DOI for Cellular uptake of radioiodine delivered by trastuzumab can be modified by the addition of epidermal growth factor.

Emergency surgery for colonic cancer in a defined population

Jestin, Pia; Nilsson, J.; Heurgren, M.; Påhlman, Lars et al.

Part of British Journal of Surgery, p. 94-100, 2005

• DOI for Emergency surgery for colonic cancer in a defined population

Epidermoid anal cancer-review of a population based series of 308 consecutive patients treated according to prospective protocols.

Nilsson, PJ; Svensson, C; Goldman, S; Ljungqvist, O et al.

Part of Int J Radiat Oncol Biol Phys: Epidermoid anal cancer-review of a population based series of 308 consecutive patients treated according to prospective protocols., p. 92-102, 2005

Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma.

Smedby, K E; Akerman, M; Hildebrand, H; Glimelius, B et al.

Part of Gut, p. 54-9, 2005

Adjuvant chemotherapy in colorectal cancer: A joint analysis of randomised trials by the Nordic Gastrointestinal Tumour Adjuvant Therapy Group.

Glimelius, Bengt; Dahl, Olav; Cedermark, Björn; Jakobsen, Anders et al.

Part of Acta Oncol, p. 904-12, 2005

Occurrence of second cancers in patients treated with radiotherapy for rectal cancer.

Birgisson, Helgi; Pahlman, Lars; Gunnarsson, Ulf; Glimelius, Bengt

Part of J Clin Oncol, p. 6126-31, 2005

Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up of the Swedish Rectal Cancer Trial.

Birgisson, Helgi; Pahlman, Lars; Gunnarsson, Ulf; Glimelius, Bengt

Part of J Clin Oncol, p. 8697-705, 2005

Improved survival in cancer of the colon and rectum in Sweden.

Birgisson, H; Talbäck, M; Gunnarsson, U; Påhlman, L et al.

Part of Eur J Surg Oncol, p. 845-53, 2005

The multidisciplinary rectal cancer treatment: main convergences, controversial aspects and investigational areas which support the need for an European Consensus.

Valentini, Vincenzo; Glimelius, Bengt; Minsky, Bruce D; Van Cutsem, Eric et al.

Part of Radiother Oncol, p. 241-50, 2005

Swedish Rectal Cancer Trial: long lasting benefits from radiotherapy on survival and local recurrence rate.

Folkesson, Joakim; Birgisson, Helgi; Pahlman, Lars; Cedermark, Bjorn et al.

Part of J Clin Oncol, p. 5644-50, 2005

Cancer staging and survival in colon cancer is dependent on the quality of the pathologists' specimen examination.

Jestin, P; Påhlman, L; Glimelius, Bengt; Gunnarsson, Ulf

Part of Eur J Cancer, p. 2071-8, 2005

Alcohol intake and risk of non-Hodgkin lymphoma in men and women

Chang, Ellen T.; Ekström Smedby, Karin; Zhang, Shumin M.; Hjalgrim, Henrik et al.

Part of Cancer Causes and Control, p. 1067-1076, 2004

• DOI for Alcohol intake and risk of non-Hodgkin lymphoma in men and women

Determinants of cancer patients' utilization of hospital care within two years after diagnosis.

Johansson, Birgitta; Holmberg, Lars; Berglund, Gunilla; Sjöden, P-O et al.

Part of Acta Oncol, p. 536-44, 2004

The circular stapling device as a risk factor for anastomotic leakage.

Folkesson, J; Nilsson, J; Påhlman, L; Glimelius, B et al.

Part of Colorectal Dis, p. 275-9, 2004

Substantial changes in life: perceptions in patients with newly diagnosed advanced cancer and their spouses.

Winterling, Jeanette; Wasteson, Elisabet; Glimelius, Bengt; Sjödén, Per-Olow et al.

Part of Cancer Nurs, p. 381-8, 2004

Phase I study of UFT plus leucovorin with radiotherapy in patients with inextirpable non-rectal gastrointestinal cancer.

Byström, P; Frödin, J-E; Berglund, A; Wilking, Nils et al.

Part of Radiother Oncol, p. 171-5, 2004

The potential for improved outcome in patients with hepatic metastases from colon cancer: a population-based study.

Sjövall, A; Järv, V; Blomqvist, L; Singnomklao, T et al.

Part of Eur J Surg Oncol, p. 834-41, 2004

Long-term sequelae after cancer therapy--a necessary consequence of success?

Glimelius, Bengt

Part of Acta Oncol, p. 132-3, 2004

Elective surgery for colorectal cancer in a defined Swedish population.

Jestin, P; Heurgren, M; Påhlman, L; Glimelius, Bengt et al.

Part of Eur J Surg Oncol, p. 26-33, 2004

Low evidence of radiation therapy in prostate cancer--a plea for intensified scientific activity.

Glimelius, Bengt; Steineck, Gunnar

Part of Acta Oncol, p. 311-5, 2004

Potential outcomes of modalities and techniques in radiotherapy for patients with hypopharyngeal carcinoma.

Johansson, Jonas; Blomquist, Erik; Montelius, Anders; Isacsson, Ulf et al.

Part of Radiother Oncol, p. 129-38, 2004

Multicenter phase II study of Nordic fluorouracil and folinic acid bolus schedule combined with oxaliplatin as first-line treatment of metastatic colorectal cancer.

Sörbye, Halfdan; Glimelius, Bengt; Berglund, Ake; Fokstuen, Tone et al.

Part of J Clin Oncol, p. 31-8, 2004

Improved survival in patients with peritoneal metastases from colorectal cancer: a preliminary study.

Mahteme, H; Hansson, J; Berglund, Åke; Påhlman, Lars et al.

Part of Br J Cancer, p. 403-7, 2004

A phase II study of UFT and Leucovorin in combination with mitomycin C in patients with metastatic colorectal cancer.

Gyldenkerne, Niels; Glimelius, Bengt; Frödin, Jan Erik; Kjaer, Mogens et al.

Part of Acta Oncol, p. 276-9, 2004

A randomised phase II multicentre trial of irinotecan (CPT-11) using four different schedules in patients with metastatic colorectal cancer.

Schoemaker, N E; Kuppens, I E L M; Moiseyenko, V; Glimelius, Bengt et al.

Part of Br J Cancer, p. 1434-41, 2004

Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease

Travis, Lois B; Hill, Deirdre A; Dores, Graça M; Gospodarowicz, Mary et al.

Part of Journal of the American Medical Association (JAMA), p. 465-475, 2003

• DOI for Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease

A novel B-cell line (U-2932) established from a patient with a diffuse large B-cell lymphoma following Hodgkin lymphoma

Amini, Rose-Marie; Berglund, Mattias; Rosenquist, Richard; von Heideman, Anne et al.

Part of Leukemia and Lymphoma, p. 2179-2189, 2002

• DOI for A novel B-cell line (U-2932) established from a patient with a diffuse large B-cell lymphoma following Hodgkin lymphoma

A population-based study of the outcome for patients with first relapse of Hodgkin lymphoma

Amini, Rose-Marie; Glimelius, Bengt; Gustavsson, Anita; Ekman, Tor et al.

Part of European Journal of Haematology, p. 225-232, 2002

• DOI for A population-based study of the outcome for patients with first relapse of Hodgkin lymphoma

Relapsed Hodgkin's lymphoma: immunostaining patterns in relation to survival

Amini, Rose-Marie; Enblad, Gunilla; Engström, Peter; Christensson, Birger et al.

Part of Leukemia and Lymphoma, p. 1253-1260, 2002

• DOI for Relapsed Hodgkin's lymphoma: immunostaining patterns in relation to survival

Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma

Molin, Daniel; Edström, Annika; Glimelius, Ingrid; Glimelius, Bengt et al.

Part of British Journal of Haematology, p. 122-124, 2002

• DOI for Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma

Lung cancer following chemotherapy and radiotherapy for Hodgkin's disease

Travis, Lois B; Gospodarowicz, Mary; Curtis, Rochelle E; Clarke, E Aileen et al.

Part of Journal of the National Cancer Institute, p. 182-192, 2002

Raltitrexed: current clinical status and future directions

Van Cutsem, E; Cunningham, D; Maroun, J; Cervantes, A et al.

Part of Annals of Oncology, p. 513-522, 2002

• DOI for Raltitrexed: current clinical status and future directions

Childbearing and the risk of leukemia in Sweden

Ekström, Karin; Wuu, Joanne; Hsieh, Chung-Cheng; Glimelius, Bengt et al.

Part of Cancer Causes & Control, p. 47-53, 2002

Radiation therapy through activation of stable nuclides.

Carlsson, Jörgen; Forssell-Aronsson, Eva; Glimelius, Bengt

Part of Acta Oncol, p. 629-34, 2002

Treatment outcome in patients younger than 60 years with advanced stages (IIB-IV) of Hodgkin's disease: the Swedish National Health Care Programme experience

Amini, Rose-Marie; Enblad, Gunilla; Gustavsson, Anita; Ekman, Tor et al.

Part of European Journal of Haematology, p. 379-389, 2000

• DOI for Treatment outcome in patients younger than 60 years with advanced stages (IIB-IV) of Hodgkin's disease: the Swedish National Health Care Programme experience

Smoking and the risk of leukemia, lymphoma, and multiple myeloma (Sweden)

Adami, Johanna; Nyrén, Olof; Bergström, Reinhold; Ekbom, Anders et al.

Part of Cancer Causes and Control, p. 49-56, 1998

• DOI for Smoking and the risk of leukemia, lymphoma, and multiple myeloma (Sweden)

Patients suffering from both Hodgkin's disease and non-Hodgkin's lymphoma: a clinico-pathological and immuno-histochemical population-based study of 32 patients

Amini, Rose-Marie; Enblad, Gunilla; Sundström, Christer; Glimelius, Bengt

Part of International Journal of Cancer, p. 510-516, 1997

• DOI for Patients suffering from both Hodgkin's disease and non-Hodgkin's lymphoma: a clinico-pathological and immuno-histochemical population-based study of 32 patients

Maternal and perinatal risk factors for childhood brain tumors (Sweden)

Linet, Martha S.; Gridley, Gloria; Cnattingius, Sven; Nicholson, H. Stacy et al.

Part of Cancer Causes and Control, p. 437-448, 1996

• DOI for Maternal and perinatal risk factors for childhood brain tumors (Sweden)

Second cancer is the leading cause of death, with no increase of cardiovascular deaths, after combined modality Hodgkin lymphoma treatment

Lagerlöf, Ingemar; Fohlin, Helena; Enblad, Gunilla; Glimelius, Bengt et al.

Recent advances in rectal cancer treatment: are we on the right track?

Glimelius, Bengt

Part of Upsala Journal of Medical Sciences, 2024

• DOI for Recent advances in rectal cancer treatment: are we on the right track?
• Download full text (pdf) of Recent advances in rectal cancer treatment: are we on the right track?

Results of a diagnostic imaging audit in a randomised clinical trial in rectal cancer highlight the importance of careful planning and quality control

Prata, Ilaria; Eriksson, Martina; Krdzalic, Jasenko; Kranenbarg, Elma Meershoek-Klein et al.

Part of Insights into Imaging, 2023

• DOI for Results of a diagnostic imaging audit in a randomised clinical trial in rectal cancer highlight the importance of careful planning and quality control
• Download full text (pdf) of Results of a diagnostic imaging audit in a randomised clinical trial in rectal cancer highlight the importance of careful planning and quality control

Metastatic colorectal cancer: Advances in the folate-fluoropyrimidine chemotherapy backbone

Glimelius, Bengt; Stintzing, Sebastian; Marshall, John; Yoshino, Takayuki et al.

Part of Cancer Treatment Reviews, 2021

• DOI for Metastatic colorectal cancer: Advances in the folate-fluoropyrimidine chemotherapy backbone
• Download full text (pdf) of Metastatic colorectal cancer: Advances in the folate-fluoropyrimidine chemotherapy backbone

Moderators of the effect of psychosocial interventions on fatigue in women with breast cancer and men with prostate cancer: Individual patient data meta-analyses

Abrahams, Harriët J. G.; Knoop, Hans; Schreurs, Maartje; Aaronson, Neil K. et al.

Part of Psycho-Oncology, p. 1772-1785, 2020

• DOI for Moderators of the effect of psychosocial interventions on fatigue in women with breast cancer and men with prostate cancer: Individual patient data meta-analyses

Recurrence Risk after Radical Colorectal Cancer Surgery: Less Than before, But How High Is It?

Osterman, Erik; Hammarström, Klara; Imam, Israa; Österlund, Emerik et al.

Part of Cancers, 2020

• DOI for Recurrence Risk after Radical Colorectal Cancer Surgery: Less Than before, But How High Is It?
• Download full text (pdf) of Recurrence Risk after Radical Colorectal Cancer Surgery: Less Than before, But How High Is It?

Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients

Glimelius, Bengt; Osterman, Erik

Part of Cancers, 2020

• DOI for Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients
• Download full text (pdf) of Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients

Effects and moderators of coping skills training on symptoms of depression and anxiety in patients with cancer: Aggregate data and individual patient data meta-analyses

Buffart, L. M.; Schreurs, M. A. C.; Abrahams, H. J. G.; Kalter, J. et al.

Part of Clinical Psychology Review, 2020

• DOI for Effects and moderators of coping skills training on symptoms of depression and anxiety in patients with cancer: Aggregate data and individual patient data meta-analyses

Adjuvant chemotherapy in rectal cancer: state of the art and future perspectives

Glimelius, Bengt

Part of Current Opinion in Oncology, p. 377-383, 2020

• DOI for Adjuvant chemotherapy in rectal cancer: state of the art and future perspectives

Reporting of patient characteristics and stratification factors in phase 3 trials investigating first-line systemic treatment of metastatic colorectal cancer: A systematic review

Goey, Kaitlyn K. H.; Mahmoud, Remi; Sørbye, Halfdan; Glimelius, Bengt et al.

Part of European Journal of Cancer, p. 115-124, 2018

• DOI for Reporting of patient characteristics and stratification factors in phase 3 trials investigating first-line systemic treatment of metastatic colorectal cancer: A systematic review

Effects and moderators of psychosocial interventions on quality of life, and emotional and social function in patients with cancer: An individual patient data meta-analysis of 22 RCTs

Kalter, J.; Verdonck-de Leeuw, I. M.; Sweegers, M. G.; Aaronson, N. K. et al.

Part of Psycho-Oncology, p. 1150-1161, 2018

• DOI for Effects and moderators of psychosocial interventions on quality of life, and emotional and social function in patients with cancer: An individual patient data meta-analysis of 22 RCTs

Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease

ter Veer, Emil; van Rijssen, L. Bengt; Besselink, Marc G.; Mali, Rosa M. A. et al.

Part of The Lancet Oncology, 2018

• DOI for Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease

On a prolonged interval between rectal cancer (chemo) radiotherapy and surgery

Glimelius, Bengt

Part of Upsala Journal of Medical Sciences, p. 1-10, 2017

• DOI for On a prolonged interval between rectal cancer (chemo) radiotherapy and surgery
• Download full text (pdf) of On a prolonged interval between rectal cancer (chemo) radiotherapy and surgery

Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature

Bockelman, Camilla; Engelmann, Bodil E.; Kaprio, Tuomas; Hansen, Torben F. et al.

Part of Acta Oncologica, p. 5-16, 2015

• DOI for Risk of recurrence in patients with colon cancer stage II and III: A systematic review and meta-analysis of recent literature

Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013

Papamichael, D.; Audisio, R. A.; Glimelius, Bengt; de Gramont, A. et al.

Part of Annals of Oncology, p. 463-476, 2015

• DOI for Treatment of colorectal cancer in older patients: International Society of Geriatric Oncology (SIOG) consensus recommendations 2013

Guidelines for time-to-event end-point definitions in trials for pancreatic cancer: Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials)

Bonnetain, Franck; Bonsing, Bert; Conroy, Thierry; Dousseau, Adelaide et al.

Part of European Journal of Cancer, p. 2983-2993, 2014

• DOI for Guidelines for time-to-event end-point definitions in trials for pancreatic cancer: Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials)

Quality assurance and quality control for radiotherapy/medical oncology in Europe: Guideline development and implementation

Valentini, V.; Glimelius, Bengt; Frascino, V.

Part of European Journal of Surgical Oncology, p. 938-944, 2013

• DOI for Quality assurance and quality control for radiotherapy/medical oncology in Europe: Guideline development and implementation

Window-of-opportunity trials to evaluate clinical activity of new molecular entities in oncology

Glimelius, Bengt; Lahn, M.

Part of Annals of Oncology, p. 1717-1725, 2011

• DOI for Window-of-opportunity trials to evaluate clinical activity of new molecular entities in oncology

Treatment of the elderly colorectal cancer patient: SIOG expert recommendations

Papamichael, D.; Audisio, R.; Horiot, J. -C; Glimelius, Bengt et al.

Part of Annals of Oncology, p. 5-16, 2009

• DOI for Treatment of the elderly colorectal cancer patient: SIOG expert recommendations

Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel

Nordlinger, B.; Van Cutsem, E.; Gruenberger, T.; Glimelius, Bengt et al.

Part of Annals of Oncology, p. 985-992, 2009

• DOI for Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel

Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2)

Valentini, Vincenzo; Aristei, Cynthia; Glimelius, Bengt; Minsky, Bruce D et al.

Part of Radiotherapy and Oncology, p. 148-163, 2009

• DOI for Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2)

Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer?: A report from the European Colorectal Metastases Treatment Group

Nordlinger, Bernard; Van Cutsem, Eric; Rougier, Philippe; Köhne, Claus-Henning et al.

Part of European Journal of Cancer, p. 2037-2045, 2007

• DOI for Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer?: A report from the European Colorectal Metastases Treatment Group

Rectal cancer irradiation. Long course, short course or something else?

Glimelius, Bengt

Part of Acta Oncol, p. 1013-7, 2006

Role of radiotherapy

Påhlman, Lars; Glimelius, Bengt

Part of International Handbook of colorectal cancer, p. 57-70, Euromed Communications Ltd, 2008

Role of radiotherapy

Påhlman, Lars; Glimelius, Bengt

Part of International Handbook of Colorectal Cancer, p. 57-70, Euromed Commincations Ltd, 2008

Prognostic significance of SATB1 expression in metastatic colorectal cancer: A Nordic prospective cohort study.

Siesing, Christina; Sorbye, Halfdan; Dragomir, Anca; Pfeiffer, Per et al.

Part of ASCO 2018 Gastrointestinal Cancers Symposium, p. 707-707, 2018

• DOI for Prognostic significance of SATB1 expression in metastatic colorectal cancer: A Nordic prospective cohort study.

Expression of podocalyxin-like protein and epidermal growth factor receptor in metastatic colorectal cancer: Prognostic impact and relationship with response to cetuximab.

Larsson, Anna; Karnevi, Emelie; Nodin, Bjorn; Sorbye, Halfdan et al.

2018

BM and CEA as Serum Markers in Detecting Colorectal Cancer Recurrence: A Comparative Study

D, J; Osterman, Erik; C, C; G, M et al.

Impact of new MRI-guidelines on nodal staging and the use of preoperative (chemo)radiotherapy in rectal cancer

Collin, Åsa; Folkesson, Joakim; Glimelius, Bengt

Primary tumor location, molecular alterations, treatment, and outcome in a population-based metastatic colorectal cancer cohort

Osterlund, Emerik; Hammarström, Klara; Nunes, Luís; Mathot, Lucy et al.